form10-q.htm
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
10-Q
(Mark
One)
x
|
QUARTERLY REPORT PURSUANT TO
SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
1934
|
For the
quarterly period ended June 30, 2008.
OR
o
|
TRANSITION REPORT PURSUANT TO
SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
1934
|
For the
transition period from __________ to __________
Commission
File Number: 0-21184
MICROCHIP
TECHNOLOGY INCORPORATED
(Exact
Name of Registrant as Specified in Its Charter)
Delaware
|
|
86-0629024
|
(State
or Other Jurisdiction of Incorporation or Organization)
|
|
(IRS
Employer Identification No.)
|
2355
W. Chandler Blvd., Chandler, AZ 85224-6199
(480)
792-7200
(Address,
Including Zip Code, and Telephone Number,
Including
Area Code, of Registrant’s
Principal
Executive Offices)
Indicate
by checkmark whether the registrant (1) has filed all reports required to be
filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the
preceding 12 months (or for such shorter period that the registrant was required
to file such reports), and (2) has been subject to the filing requirements for
the past 90 days.
Yes x No ¨
Indicate
by check mark whether the registrant is a large accelerated filer, an
accelerated filer, a non-accelerated filer, or a smaller reporting
company. See definitions of “large accelerated filer” “accelerated
filer” and “smaller reporting company” in Rule 12b-2 of the Exchange
Act):
Large
accelerated filer
|
ý
|
Accelerated
filer
|
¨
|
Non-accelerated
filer
|
¨
|
Smaller
reporting company
|
¨
|
(Do not
check if a smaller reporting company)
Indicate
by check mark whether the registrant is a shell company (as defined in Rule
12b-2 of the Exchange Act). (Check One)
Yes ¨ No x
Shares
Outstanding of Registrant’s Common Stock
|
Class
|
Outstanding
at July 31, 2008
|
Common
Stock, $0.001 par value
|
184,126,571
shares
|
MICROCHIP
TECHNOLOGY INCORPORATED AND SUBSIDIARIES
INDEX
|
|
Page
|
|
|
|
PART
I. FINANCIAL INFORMATION
|
|
|
|
|
Item
1.
|
Financial
Statements (Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CERTIFICATIONS
|
|
|
|
EXHIBITS
|
|
MICROCHIP
TECHNOLOGY INCORPORATED AND SUBSIDIARIES
(in
thousands, except share and per share amounts)
ASSETS
|
|
|
|
June
30,
|
|
|
March
31,
|
|
|
|
2008
|
|
|
2008
|
|
|
|
(Unaudited)
|
|
|
(Note
1)
|
|
Cash
and cash equivalents
|
|
$ |
685,575 |
|
|
$ |
487,736 |
|
Short-term
investments
|
|
|
353,588 |
|
|
|
837,054 |
|
Accounts
receivable, net
|
|
|
135,753 |
|
|
|
138,319 |
|
Inventories
|
|
|
125,798 |
|
|
|
124,483 |
|
Prepaid
expenses
|
|
|
17,348 |
|
|
|
17,135 |
|
Deferred
tax assets
|
|
|
66,619 |
|
|
|
63,261 |
|
Other
current assets
|
|
|
46,654 |
|
|
|
49,742 |
|
Total current
assets
|
|
|
1,431,335 |
|
|
|
1,717,730 |
|
|
|
|
|
|
|
|
|
|
Property,
plant and equipment, net
|
|
|
520,790 |
|
|
|
522,305 |
|
Long-term
investments
|
|
|
513,555 |
|
|
|
194,274 |
|
Goodwill
|
|
|
31,886 |
|
|
|
31,886 |
|
Intangible
assets, net
|
|
|
11,331 |
|
|
|
11,613 |
|
Other
assets
|
|
|
34,541 |
|
|
|
34,499 |
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
$ |
2,543,438 |
|
|
$ |
2,512,307 |
|
|
|
|
|
|
|
|
|
|
LIABILITIES
AND STOCKHOLDERS' EQUITY
|
|
|
|
|
|
|
|
|
|
|
Accounts
payable
|
|
$ |
47,769 |
|
|
$ |
39,317 |
|
Accrued
liabilities
|
|
|
49,627 |
|
|
|
56,323 |
|
Deferred
income on shipments to distributors
|
|
|
97,125 |
|
|
|
95,441 |
|
Total current
liabilities
|
|
|
194,521 |
|
|
|
191,081 |
|
|
|
|
|
|
|
|
|
|
Junior
convertible debentures
|
|
|
1,150,227 |
|
|
|
1,150,128 |
|
Long-term
income tax payable
|
|
|
117,674 |
|
|
|
112,311 |
|
Deferred
tax liability
|
|
|
27,353 |
|
|
|
21,460 |
|
Other
long-term liabilities
|
|
|
1,135 |
|
|
|
1,104 |
|
|
|
|
|
|
|
|
|
|
Stockholders’
equity:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred
stock, $0.001 par value; authorized 5,000,000 shares;
|
|
|
|
|
|
|
|
|
no shares issued or
outstanding.
|
|
|
--- |
|
|
|
--- |
|
Common
stock, $0.001 par value; 450,000,000 shares authorized;
|
|
|
|
|
|
|
|
|
218,789,994 shares issued and
184,466,686 shares outstanding at June 30, 2008;
218,789,994
shares issued and 184,338,768 shares outstanding at March 31,
2008.
|
|
|
184 |
|
|
|
184 |
|
Additional
paid-in capital
|
|
|
788,233 |
|
|
|
793,919 |
|
Retained
earnings
|
|
|
1,316,609 |
|
|
|
1,301,275 |
|
Accumulated
other comprehensive (loss) income
|
|
|
(711 |
) |
|
|
2,508 |
|
Common
stock held in treasury: 34,323,308 shares at June 30,2008;
34,451,226 shares at March 31, 2008.
|
|
|
(1,051,787 |
) |
|
|
(1,061,663 |
) |
Total stockholders’
equity
|
|
|
1,052,528 |
|
|
|
1,036,223 |
|
Total liabilities and
stockholders’ equity
|
|
$ |
2,543,438 |
|
|
$ |
2,512,307 |
|
|
|
|
|
|
|
|
|
|
See
accompanying notes to condensed consolidated financial
statements
|
|
MICROCHIP
TECHNOLOGY INCORPORATED AND SUBSIDIARIES
(in
thousands except per share amounts)
(Unaudited)
|
|
Three
Months Ended June 30,
|
|
|
|
2008
|
|
|
2007
|
|
|
|
|
|
|
|
|
Net
sales
|
|
$ |
268,172 |
|
|
$ |
264,072 |
|
Cost
of sales (1)
|
|
|
104,575 |
|
|
|
105,527 |
|
Gross
profit
|
|
|
163,597 |
|
|
|
158,545 |
|
|
|
|
|
|
|
|
|
|
Operating
expenses:
|
|
|
|
|
|
|
|
|
Research
and development (1)
|
|
|
31,552 |
|
|
|
29,746 |
|
Selling,
general and administrative (1)
|
|
|
45,413 |
|
|
|
43,780 |
|
|
|
|
76,965 |
|
|
|
73,526 |
|
|
|
|
|
|
|
|
|
|
Operating
income
|
|
|
86,632 |
|
|
|
85,019 |
|
|
|
|
|
|
|
|
|
|
Other
income (expense):
|
|
|
|
|
|
|
|
|
Interest
income
|
|
|
10,199 |
|
|
|
14,902 |
|
Interest
expense
|
|
|
(6,401 |
) |
|
|
--- |
|
Other,
net
|
|
|
2,745 |
|
|
|
822 |
|
Income
before income taxes
|
|
|
93,175 |
|
|
|
100,743 |
|
Income
tax provision
|
|
|
16,865 |
|
|
|
20,450 |
|
Net
income
|
|
$ |
76,310 |
|
|
$ |
80,293 |
|
|
|
|
|
|
|
|
|
|
Basic
net income per common share
|
|
$ |
0.41 |
|
|
$ |
0.37 |
|
Diluted
net income per common share
|
|
$ |
0.40 |
|
|
$ |
0.36 |
|
Dividends
declared per common share
|
|
$ |
0.330 |
|
|
$ |
0.280 |
|
|
|
|
|
|
|
|
|
|
Diluted
common shares outstanding
|
|
|
184,663 |
|
|
|
218,111 |
|
Basic
common shares outstanding
|
|
|
191,049 |
|
|
|
223,592 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
Includes share-based compensation expense as follow:
|
|
|
|
|
|
Cost
of sales
|
|
$ |
1,625 |
|
|
$ |
1,590 |
|
Research
and development
|
|
|
2,435 |
|
|
|
2,586 |
|
Selling,
general and administrative
|
|
|
3,639 |
|
|
|
3,857 |
|
|
|
|
|
|
|
|
|
|
See
accompanying notes to condensed consolidated financial
statements
|
|
MICROCHIP
TECHNOLOGY INCORPORATED AND SUBSIDIARIES
(in
thousands)
(Unaudited)
|
|
Three
months ended June 30,
|
|
|
|
2008
|
|
|
2007
|
|
Cash
flows from operating activities:
|
|
|
|
|
|
|
Net
income
|
|
$ |
76,310 |
|
|
$ |
80,293 |
|
Adjustments
to reconcile net income to net cash provided by operating
|
|
|
|
|
|
|
|
|
activities:
|
|
|
|
|
|
|
|
|
Depreciation
and amortization
|
|
|
23,766 |
|
|
|
26,898 |
|
Deferred
income taxes
|
|
|
3,410 |
|
|
|
(3,087 |
) |
Share-based
compensation expense related to equity incentive plans
|
|
|
7,699 |
|
|
|
8,033 |
|
Excess
tax benefit from share-based compensation
|
|
|
(5,178 |
) |
|
|
(8,674 |
) |
Tax
benefit from equity incentive plans
|
|
|
5,928 |
|
|
|
8,767 |
|
Convertible
debt derivatives – revaluation and amortization
|
|
|
99 |
|
|
|
--- |
|
Amortization
of convertible debenture issuance costs
|
|
|
192 |
|
|
|
--- |
|
Gain
on sale of assets
|
|
|
(94 |
) |
|
|
(450 |
) |
Purchases
of trading securities
|
|
|
(1,021 |
) |
|
|
--- |
|
Gain
on trading securities
|
|
|
(1,417 |
) |
|
|
--- |
|
Unrealized
impairment loss on available-for-sale investments
|
|
|
894 |
|
|
|
--- |
|
Changes
in operating assets and liabilities:
|
|
|
|
|
|
|
|
|
Decrease
(increase) in accounts receivable
|
|
|
2,566 |
|
|
|
(2,761 |
) |
Increase
in inventories
|
|
|
(1,537 |
) |
|
|
(2,709 |
) |
Increase
(decrease) in deferred income on shipments to distributors
|
|
|
1,684 |
|
|
|
(1,431 |
) |
Increase
in accounts payable and accrued liabilities
|
|
|
1,756 |
|
|
|
23,148 |
|
Change
in other assets and liabilities
|
|
|
8,036 |
|
|
|
(5,397 |
) |
Net
cash provided by operating activities
|
|
|
123,093 |
|
|
|
122,630 |
|
|
|
|
|
|
|
|
|
|
Cash
flows from investing activities:
|
|
|
|
|
|
|
|
|
Purchases
of available-for-sale investments
|
|
|
(3,500 |
) |
|
|
(531,291 |
) |
Sales
and maturities of available-for-sale investments
|
|
|
165,135 |
|
|
|
465,360 |
|
Investment
in other assets
|
|
|
(237 |
) |
|
|
(398 |
) |
Proceeds
from sale of assets
|
|
|
109 |
|
|
|
450 |
|
Capital
expenditures
|
|
|
(21,747 |
) |
|
|
(25,470 |
) |
Net
cash provided by (used in) investing activities
|
|
|
139,760 |
|
|
|
(91,349 |
) |
|
|
|
|
|
|
|
|
|
Cash
flows from financing activities:
|
|
|
|
|
|
|
|
|
Payment
of cash dividend
|
|
|
(60,977 |
) |
|
|
(61,119 |
) |
Repurchase
of common stock
|
|
|
(23,637 |
) |
|
|
--- |
|
Proceeds
from sale of common stock
|
|
|
14,422 |
|
|
|
21,690 |
|
Excess
tax benefit from share-based compensation
|
|
|
5,178 |
|
|
|
8,674 |
|
Net
cash used in financing activities
|
|
|
(65,014 |
) |
|
|
(30,755 |
) |
Net
increase in cash and cash equivalents
|
|
|
197,839 |
|
|
|
526 |
|
Cash
and cash equivalents at beginning of period
|
|
|
487,736 |
|
|
|
167,477 |
|
Cash
and cash equivalents at end of period
|
|
$ |
685,575 |
|
|
$ |
168,003 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
See
accompanying notes to condensed consolidated financial
statements
|
|
MICROCHIP
TECHNOLOGY INCORPORATED AND SUBSIDIARIES
(Unaudited)
(1)
|
Basis of
Presentation
|
The
accompanying unaudited condensed consolidated financial statements include the
accounts of Microchip Technology Incorporated and its wholly-owned subsidiaries
(the “Company”). All intercompany balances and transactions have been
eliminated in consolidation. The Company owns 100% of the outstanding
stock in all of its subsidiaries.
The
accompanying unaudited condensed consolidated financial statements have been
prepared in accordance with generally accepted accounting principles in the
United States of America, pursuant to the rules and regulations of the
Securities and Exchange Commission (the “SEC”). In the opinion of
management, all adjustments of a normal recurring nature which are necessary for
a fair presentation have been included. Certain information and
footnote disclosures normally included in audited consolidated financial
statements have been condensed or omitted pursuant to such SEC rules and
regulations. It is suggested that these condensed consolidated
financial statements be read in conjunction with the audited consolidated
financial statements and the notes thereto included in the Company’s Annual
Report on Form 10-K for the fiscal year ended March 31, 2008. The
results of operations for the three months ended June 30, 2008 are not
necessarily indicative of the results that may be expected for the fiscal year
ending March 31, 2009 or for any other period.
(2)
|
Recently Issued
Accounting Pronouncements
|
In
September 2006, the Financial Accounting Standards Board (FASB) issued Statement
of Financial Accounting Standards (SFAS) No. 157, Fair Value Measurement (SFAS
No. 157). SFAS No. 157 defines fair value, establishes a framework for
measuring fair value in accordance with generally accepted accounting
principles, and expands disclosures about fair value measurements. In
February 2008, the FASB issued FASB Staff Position (FSP) FAS 157-2, Effective Date of FASB Statement No.
157 (FSP FAS 157-2), which delays the effective date of SFAS No. 157 for
all nonfinancial assets and liabilities except for those recognized or disclosed
at least annually. The Company adopted SFAS No. 157 on April 1, 2008, which had
no impact on the Company's consolidated results of operations or financial
condition. Refer to Note 4 for additional information related to the
adoption of SFAS No. 157.
In
December 2007, the FASB issued SFAS No. 141 (revised 2007), Business Combinations (SFAS
No. 141R). SFAS No. 141R establishes principles and requirements for how
an acquirer recognizes and measures in its financial statements the identifiable
assets acquired, the liabilities assumed, any noncontrolling interest in the
acquiree and the goodwill acquired. SFAS No. 141R also establishes disclosure
requirements to enable the evaluation of the nature and financial effects of the
business combination. SFAS No. 141R is effective for fiscal years beginning
after December 15, 2008, and will be adopted by the Company in the first quarter
of fiscal 2010. The Company is currently evaluating the potential
impact, if any, of the adoption of SFAS No. 141R on its consolidated results of
operations and financial condition.
In
December 2007, the FASB issued SFAS No. 160, Noncontrolling Interests in
Consolidated Financial Statements—an amendment of Accounting Research Bulletin
No. 51 (SFAS No. 160). SFAS No. 160 establishes accounting and
reporting standards for ownership interests in subsidiaries held by parties
other than the parent, the amount of consolidated net income attributable to the
parent and to the noncontrolling interest, changes in a parent's ownership
interest, and the valuation of retained noncontrolling equity investments when a
subsidiary is deconsolidated. SFAS No. 160 also establishes disclosure
requirements that clearly identify and distinguish between the interests of the
parent and the interests of the noncontrolling owners. SFAS No. 160 is
effective for fiscal years beginning after December 15, 2008, and will be
adopted by the Company in the first quarter of fiscal 2010. The Company is
currently evaluating the potential impact, if any, the adoption of SFAS 160 will
have on its consolidated results of operations and financial
condition.
In March
2008, the FASB issued SFAS No. 161, Disclosures about Derivative Instruments
and Hedging Activities—an
amendment of FASB Statement No. 133 (SFAS No. 161). The standard
requires additional quantitative disclosures (provided in tabular form) and
qualitative disclosures for derivative instruments. The required
disclosures include how derivative instruments and related hedged items affect
an entity’s financial
position,
financial performance, and cash flows; relative volume of derivative activity;
the objectives and strategies for using derivative instruments; the accounting
treatment for those derivative instruments formally designated as the hedging
instrument in a hedge relationship; and the existence and nature of
credit-related contingent features for derivatives. SFAS No. 161 does not change
the accounting treatment for derivative instruments. SFAS No. 161 is effective
for the Company beginning January 1, 2009. The Company does not expect the
adoption of SFAS No. 161 to have a material impact on its financial condition,
results of operations or cash flows.
In May
2008, the FASB released FSP APB 14-1 Accounting For Convertible Debt
Instruments That May Be Settled in Cash Upon Conversion (Including Partial Cash
Settlement) (FSP APB 14-1) that alters the accounting treatment for
convertible debt instruments that allow for either mandatory or optional cash
settlements. FSP APB 14-1, will impact the accounting associated with
the Company's $1.15 billion junior subordinated convertible debentures.
FSP APB 14-1 specifies that issuers of such instruments should separately
account for the liability and equity components in a manner that will reflect
the entity’s nonconvertible debt borrowing rate when interest cost is recognized
in subsequent periods, and will require the Company to recognize additional
(non-cash) interest expense based on the market rate for similar debt
instruments without the conversion feature. Furthermore, FSP APB 14-1
would require the Company to recognize interest expense in prior periods
pursuant to retrospective accounting treatment. FSP APB 14-1 will
have no impact on the Company’s actual past or future cash
flows. This FSP is effective for financial statements issued for
fiscal years beginning after December 15, 2008, and will be adopted by the
Company on April 1, 2009. The Company is currently evaluating the impact
the adoption of FSP APB 14-1 will have on its consolidated results of operations
and financial condition.
(3) Investments
The
Company’s investments are intended to establish a high-quality portfolio that
preserves principal, meets liquidity needs, avoids inappropriate concentrations,
and delivers an appropriate yield in relationship to the Company’s investment
guidelines and market conditions. The following is a summary of
available-for-sale and trading securities at June 30, 2008 (amounts in
thousands):
|
|
Available-for-sale
Securities
|
|
|
|
Adjusted
Cost
|
|
|
Gross
Unrealized Gains
|
|
|
Gross
Unrealized Losses
|
|
|
Estimated
Fair
Value
|
|
Government
agency bonds
|
|
$ |
264,405 |
|
|
$ |
289 |
|
|
$ |
592 |
|
|
$ |
264,102 |
|
Municipal
bonds
|
|
|
458,605 |
|
|
|
2,197 |
|
|
|
1,573 |
|
|
|
459,229 |
|
Auction
rate securities
|
|
|
56,142 |
|
|
|
--- |
|
|
|
1,175 |
|
|
|
54,967 |
|
Corporate
bonds
|
|
|
60,000 |
|
|
|
--- |
|
|
|
23 |
|
|
|
59,977 |
|
|
|
$ |
839,152 |
|
|
$ |
2,486 |
|
|
$ |
3,363 |
|
|
$ |
838,275 |
|
|
|
Trading
Securities
|
|
|
|
Adjusted
Cost
|
|
|
Gross
Unrealized Gains
|
|
|
Gross
Unrealized Losses
|
|
|
Estimated
Fair
Value
|
|
Marketable
securities
|
|
$ |
13,154 |
|
|
$ |
1,702 |
|
|
$ |
58 |
|
|
$ |
14,798 |
|
Restricted
cash
|
|
|
14,070 |
|
|
|
--- |
|
|
|
--- |
|
|
|
14,070 |
|
|
|
$ |
27,224 |
|
|
$ |
1,702 |
|
|
$ |
58 |
|
|
$ |
28,868 |
|
At June
30, 2008, the Company’s available-for-sale securities are presented on the
condensed consolidated balance sheet as short-term investments of $353.6 million
and long-term investments of $513.6 million.
The
$14.8 million in marketable securities listed above relates to strategic
investments in publicly traded companies. The Company has classified
the shares owned in these companies as trading securities. During the
first quarter of fiscal 2009, the Company recognized a net unrealized gain in
earnings of $1.6 million on
these
trading securities. The Company also holds restricted cash of
$14.1 million as cash collateral for put options the Company has written on
one of its trading securities. The Company recorded the value
received at the date the puts were written within other current liabilities at
an amount equal to the cash received at that time. The Company
records the change in the fair value of the puts in other income, net at each
balance sheet date. At June 30, 2008, the fair value of the puts of
$0.6 million was recorded in other current liabilities. These put
options have final maturities in September and December 2008 and if the stock
price of the investment falls below the strike price of the puts, the Company
may need to make an additional investment at the designated strike price of the
puts.
At June
30, 2008, $59.5 million of the Company’s investment portfolio was invested in
auction rate securities. Historically, the carrying value of auction
rate securities approximated fair value due to the frequent resetting of the
interest rates. If an auction fails for amounts the Company has invested,
the investment will not be liquid. With the recent liquidity issues
experienced in the global credit and capital markets, the Company’s auction rate
securities have experienced multiple failed auctions. In
September 2007 and February 2008, auctions for $24.9 million and $34.8
million, respectively, of the original purchase value of the Company’s
investments in auction rate securities had first failed. While the Company
continues to earn interest on these investments based on a pre-determined
formula with spreads tied to particular interest rate indexes, the estimated
market value for a portion of these auction rate securities no longer
approximates the original purchase value.
The $24.9
million of auction rate securities that failed during September 2007 are
all AA rated by Standard & Poors and all but $2.5 million of the securities
possesses credit enhancement in the form of insurance for principal and
interest. The underlying characteristics of $22.4 million of these
auction rate securities relate to servicing statutory requirements in the life
insurance industry and $2.5 million relates to a specialty finance company that
has a AAA Standard & Poors rating and the issue owned by the Company has a
AA rating from Standard & Poors. The $24.9 million in failed auctions
have continued to fail through the filing date of this report. As a
result, the Company will not be able to access such funds until a future auction
on these investments is successful. The fair value of the failed auction
rate securities has been estimated based on market information and estimates
determined by management and could change significantly based on market
conditions. Based on the estimated values, the Company concluded these
investments were other than temporarily impaired and recognized an impairment
charge on these investments of $2.4 million during fiscal 2008 and $0.9 million
during the first quarter of fiscal 2009. If the issuers are unable to
successfully close future auctions or if their credit ratings deteriorate, the
Company may be required to further adjust the carrying value of the investments
through an impairment charge to earnings.
The $34.8
million of auction rate securities that failed during February 2008 are
investments in student loan-backed municipal bond auction rate
securities. During the first quarter of fiscal 2009, $0.2 million of
these auction rate securities were redeemed at par by the issuer, reducing the
Company’s overall position to $34.6 million. Based upon the Company’s
evaluation of available information, it believes these investments are of high
credit quality, as all of the investments carry at least two AAA credit ratings
and are largely backed by the federal government (Federal Family Education Loan
Program). The fair value of the failed auction rate securities has
been estimated based on market information and estimates determined by
management and could change significantly based on market
conditions.
The
Company continues to monitor the market for auction rate securities and consider
its impact, if any, on the fair market value of its investments. If the
market conditions deteriorate further, the Company may be required to record
additional unrealized losses in other comprehensive income or impairment
charges. The Company intends and has the ability to hold these auction
rate securities until the market recovers as it does not anticipate having to
sell these securities to fund the operations of its business. The Company
believes that, based on its current unrestricted cash, cash equivalents and
short-term investment balances, the current lack of liquidity in the credit and
capital markets will not have a material impact on its liquidity, cash flow or
ability to fund its operations.
At June
30, 2008, the Company evaluated its investment portfolio, and noted unrealized
losses of $3.4 million which were due to fluctuations in interest rates and
credit market conditions. Management does not believe any of the
unrealized losses represent an other-than-temporary impairment based on its
evaluation of
available
evidence as of June 30, 2008. The Company’s intent is to hold these
investments to such time as these assets are no longer impaired. For
those investments not scheduled to mature until after June 30, 2009, such
recovery is not anticipated to occur in the next year and these investments have
been classified as long-term investments.
The
amortized cost and estimated fair value of the available-for-sale securities at
June 30, 2008, by maturity, are shown below (amounts in
thousands). Expected maturities can differ from contractual
maturities because the issuers of the securities may have the right to prepay
obligations without prepayment penalties, and the Company views its
available-for-sale securities as available for current operations.
|
|
Adjusted
Cost
|
|
|
Gross
Unrealized Gains
|
|
|
Gross
Unrealized Losses
|
|
|
Estimated
Fair
Value
|
|
Available-for-sale
|
|
|
|
|
|
|
|
|
|
|
|
|
Due
in one year or less
|
|
$ |
69,383 |
|
|
$ |
252 |
|
|
$ |
--- |
|
|
$ |
69,635 |
|
Due
after one year and through five years
|
|
|
713,627 |
|
|
|
2,234 |
|
|
|
2,188 |
|
|
|
713,673 |
|
Due
after five years and through ten years
|
|
|
--- |
|
|
|
--- |
|
|
|
--- |
|
|
|
--- |
|
Due
after ten years
|
|
|
56,142 |
|
|
|
--- |
|
|
|
1,175 |
|
|
|
54,967 |
|
|
|
$ |
839,152 |
|
|
$ |
2,486 |
|
|
$ |
3,363 |
|
|
$ |
838,275 |
|
The
following is a summary of available-for-sale and trading securities at March 31,
2008 (amounts in thousands):
|
|
Available-for-sale
Securities
|
|
|
|
Adjusted
Cost
|
|
|
Gross
Unrealized Gains
|
|
|
Gross
Unrealized Losses
|
|
|
Estimated
Fair
Value
|
|
Government
agency bonds
|
|
$ |
397,708 |
|
|
$ |
1,933 |
|
|
$ |
--- |
|
|
$ |
399,641 |
|
Municipal
bonds
|
|
|
463,531 |
|
|
|
2,877 |
|
|
|
395 |
|
|
|
466,013 |
|
Auction
rate securities
|
|
|
57,236 |
|
|
|
--- |
|
|
|
1,095 |
|
|
|
56,141 |
|
Corporate
bonds
|
|
|
80,000 |
|
|
|
--- |
|
|
|
102 |
|
|
|
79,898 |
|
|
|
$ |
998,475 |
|
|
$ |
4,810 |
|
|
$ |
1,592 |
|
|
$ |
1,001,693 |
|
|
|
Trading
Securities
|
|
|
|
Adjusted
Cost
|
|
|
Gross
Unrealized Gains
|
|
|
Gross
Unrealized Losses
|
|
|
Estimated
Fair
Value
|
|
Marketable
securities
|
|
$ |
12,133 |
|
|
$ |
227 |
|
|
$ |
--- |
|
|
$ |
12,360 |
|
Restricted
cash
|
|
|
17,275 |
|
|
|
--- |
|
|
|
--- |
|
|
|
17,275 |
|
|
|
$ |
29,408 |
|
|
$ |
227 |
|
|
$ |
--- |
|
|
$ |
29,635 |
|
At March
31, 2008, the Company’s available-for-sale securities are presented on the
condensed consolidated balance sheet as short-term investments of $837.1 million
and long-term investments of $194.3 million.
During
the quarter ended June 30, 2008, the Company did not have any gross realized
gains or losses on sales of available-for-sale securities.
(4) Fair
Value Measurements
As
described in Note 2, the Company adopted SFAS No. 157 on April 1,
2008. SFAS No. 157, among other things, defines fair value, establishes a
consistent framework for measuring fair value and expands disclosure for each
major asset and liability category measured at fair value on either a recurring
or nonrecurring basis. SFAS No. 157 clarifies that fair value is an exit
price, representing the amount that would be received to sell an asset or paid
to transfer a liability in an orderly transaction between market participants.
As such, fair value
is a
market-based measurement that should be determined based on assumptions that
market participants would use in pricing an asset or liability. As a basis for
considering such assumptions, SFAS No. 157 establishes a three-tier fair
value hierarchy, which prioritizes the inputs used in measuring fair value as
follows:
|
Level
1 – Observable inputs such as quoted prices in active
markets;
|
|
Level
2 – Inputs, other than the quoted prices in active markets, that are
observable either directly or indirectly;
and
|
|
Level
3 – Unobservable inputs in which there is little or no market data, which
require the reporting entity to develop its own
assumptions.
|
Assets and liabilities
measured at fair value on a recurring basis at June 30, 2008 are as follows
(amounts in thousands):
|
|
Quoted
Prices in Active Markets for identical Instruments
(Level
1)
|
|
|
Significant
Other
Observable
Inputs
(Level
2)
|
|
|
Significant
Unobservable
Inputs
(Level
3)
|
|
|
Total
Balance
|
|
|
Valuation
Technique
|
|
Assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Money
market fund deposits
|
|
$ |
627,416 |
|
|
$ |
--- |
|
|
$ |
--- |
|
|
$ |
627,416 |
|
|
|
|
Bank
time deposits
|
|
|
--- |
|
|
|
72,229 |
|
|
|
--- |
|
|
|
72,229 |
|
|
|
(1 |
) |
Government
agency bonds
|
|
|
--- |
|
|
|
264,102 |
|
|
|
--- |
|
|
|
264,102 |
|
|
|
(2 |
) |
Municipal
bonds
|
|
|
--- |
|
|
|
459,229 |
|
|
|
--- |
|
|
|
459,229 |
|
|
|
(2 |
) |
Auction
rate securities
|
|
|
--- |
|
|
|
--- |
|
|
|
54,967 |
|
|
|
54,967 |
|
|
|
(3 |
) |
Corporate
bonds
|
|
|
--- |
|
|
|
59,977 |
|
|
|
--- |
|
|
|
59,977 |
|
|
|
(2 |
) |
Marketable
securities
|
|
|
14,798 |
|
|
|
--- |
|
|
|
--- |
|
|
|
14,798 |
|
|
|
|
|
Total
assets measured at fair value
|
|
$ |
714,443 |
|
|
$ |
783,308 |
|
|
$ |
54,967 |
|
|
$ |
1,552,718 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Put
options on publicly traded common stock
|
|
$ |
560 |
|
|
$ |
--- |
|
|
$ |
--- |
|
|
$ |
560 |
|
|
|
|
|
Total
liabilities measured at fair value
|
|
$ |
560 |
|
|
$ |
--- |
|
|
$ |
--- |
|
|
$ |
560 |
|
|
|
|
|
(3) Given
the complexity of the Company’s investments in auction rate securities, the
Company engaged an investment advisor to assist in determining the fair values
of its investments. The Company, with the assistance of its advisor, estimated
the fair value of these auction rate securities based on the following:
(i) the underlying structure of each security; (ii) the present value
of future principal and interest payments discounted at rates considered to
reflect current market conditions; (iii) consideration of the probabilities
of default, auction failure, or repurchase at par for each period; and (iv)
estimates of the recovery rates in the event of default for each security. These
estimated fair values could change significantly based on future market
conditions. Refer to Note 3 for further discussion of the Company’s investments
in auction rate securities.
The following table presents a
reconciliation for all assets and liabilities measured at fair value on a
recurring basis, excluding accrued interest components, using significant
unobservable inputs (Level 3) for the three months ended June 30,
2008:
|
|
Investments
in Auction Rate Securities
|
|
|
|
|
|
Balance
at March 31, 2008
|
|
$ |
56,141 |
|
Securities
redeemed at par
|
|
|
(200 |
) |
Unrealized
losses recorded to other comprehensive income
|
|
|
(80 |
) |
Impairment
losses included in interest income
|
|
|
(894 |
) |
Balance
at June 30, 2008
|
|
$ |
54,967 |
|
Assets
and liabilities measured at fair value on a recurring basis are
presented/classified on our condensed consolidated balance sheet at June 30,
2008 as follow (amounts in thousands):
|
|
Quoted
Prices
in
Active
Markets
for
Identical
Instruments
(Level
1)
|
|
|
Significant
Other
Observable
Inputs
(Level
2)
|
|
|
Significant
Unobservable
Inputs
(Level
3)
|
|
|
Total
Balance
|
|
Assets
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash
and cash equivalents
|
|
$ |
685,575 |
|
|
$ |
--- |
|
|
$ |
--- |
|
|
$ |
685,575 |
|
Short-term
investments
|
|
|
28,868 |
|
|
|
324,720 |
|
|
|
--- |
|
|
|
353,588 |
|
Long-term
investments
|
|
|
--- |
|
|
|
458,588 |
|
|
|
54,967 |
|
|
|
513,555 |
|
Total
assets measured at fair value
|
|
$ |
714,443 |
|
|
$ |
783,308 |
|
|
$ |
54,967 |
|
|
$ |
1,552,718 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accrued
liabilities
|
|
$ |
560 |
|
|
$ |
--- |
|
|
$ |
--- |
|
|
$ |
560 |
|
Total
liabilities measured at fair value
|
|
$ |
560 |
|
|
$ |
--- |
|
|
$ |
--- |
|
|
$ |
560 |
|
Accounts
receivable consists of the following (amounts in thousands):
|
|
June
30,
2008
|
|
|
March
31,
2008
|
|
|
|
|
|
|
|
|
Trade
accounts receivable
|
|
$ |
138,523 |
|
|
$ |
140,966 |
|
Other
|
|
|
380 |
|
|
|
505 |
|
|
|
|
138,903 |
|
|
|
141,741 |
|
Less
allowance for doubtful accounts
|
|
|
3,150 |
|
|
|
3,152 |
|
|
|
$ |
135,753 |
|
|
$ |
138,319 |
|
The
components of inventories consist of the following (amounts in
thousands):
|
|
June
30,
2008
|
|
|
March
31,
2008
|
|
|
|
|
|
|
|
|
Raw
materials
|
|
$ |
3,870 |
|
|
$ |
4,205 |
|
Work
in process
|
|
|
100,493 |
|
|
|
95,973 |
|
Finished
goods
|
|
|
21,435 |
|
|
|
24,305 |
|
|
|
$ |
125,798 |
|
|
$ |
124,483 |
|
(7)
|
Property, Plant and
Equipment
|
Property,
plant and equipment consists of the following (amounts in
thousands):
|
|
June
30,
2008
|
|
|
March
31,
2008
|
|
|
|
|
|
|
|
|
Land
|
|
$ |
39,750 |
|
|
$ |
39,764 |
|
Building
and building improvements
|
|
|
331,027 |
|
|
|
330,519 |
|
Machinery
and equipment
|
|
|
1,123,566 |
|
|
|
1,100,759 |
|
Projects
in process
|
|
|
73,578 |
|
|
|
78,073 |
|
|
|
|
1,567,921 |
|
|
|
1,549,115 |
|
Less
accumulated depreciation
and
amortization
|
|
|
1,047,131 |
|
|
|
1,026,810 |
|
|
|
$ |
520,790 |
|
|
$ |
522,305 |
|
Depreciation
expense attributed to property and equipment was $23.2 million in the three
months ended June 30, 2008 and $26.4 million in the three months ended June
30, 2007.
At
March 31, 2008, the Company had $112.3 million of unrecognized tax
benefits. Unrecognized tax benefits increased by $5.4 million in the three
months ended June 30, 2008, related to the accrual for uncertain tax
positions and the accrual of deficiency interest on these
positions.
The
Company files U.S. federal, U.S. state, and foreign income tax returns.
For U.S. federal, and in general for state tax returns, the fiscal 2002
through fiscal 2008 tax years remain open for examination by tax
authorities. For foreign tax returns, the Company is generally no longer
subject to income tax examinations for years prior to fiscal 2002.
The
Company recognizes liabilities for anticipated tax audit issues in the United
States and other tax jurisdictions based on its estimate of whether, and the
extent to which, additional tax payments are more likely than not. The
Company believes that it maintains adequate reserves to offset any potential
income tax liabilities that may arise upon final resolution of matters for open
tax years. The IRS is currently auditing the Company’s fiscal years ended
March 31, 2002, 2003 and 2004. The Company believes that it has
appropriate support for the income tax positions taken and to be taken on its
tax returns and that its accruals for tax liabilities are adequate for all open
years based on an assessment of many factors including past experience and
interpretations of tax law applied to the facts of each matter.
If such
amounts ultimately prove to be unnecessary, the resulting reversal of such
reserves would result in tax benefits being recorded in the period the reserves
are no longer deemed necessary. If such amounts ultimately prove to be
less than an ultimate assessment, a future charge to expense would be recorded
in the period in which the assessment is determined. Although timing of
the resolution and/or closure on audits is highly uncertain, the Company does
not believe it is reasonably possible that the unrecognized tax benefits would
materially change in the next 12 months.
(9) 2.125%
Junior Subordinated Convertible Debentures
In
December 2007, the Company issued $1.15 billion principal amount of 2.125%
junior subordinated convertible debentures due December 15, 2037, to two initial
purchasers in a private offering. The debentures are subordinated in
right of payment to any future senior debt of the Company and are effectively
subordinated in right of payment to the liabilities of the Company’s
subsidiaries. The debentures are convertible, subject to certain
conditions, into shares of the Company’s common stock at an initial conversion
rate of 29.2783 shares of common stock per one thousand dollar principal amount
of debentures, representing an initial conversion price of approximately $34.16
per share of common stock. As of June 30, 2008, none of the
conditions allowing holders of the debentures to convert had been
met. The conversion rate will be subject to adjustment for certain
events as outlined in the indenture governing the debentures, including in the
event the Company pays a cash dividend on its common stock, but will not be
adjusted for accrued interest. As a result of a cash dividend of
$0.33 per share paid in May 2008, the conversion rate was adjusted to 29.8366
shares of common stock per $1,000 of principal
amount of
debentures, representing a conversion price of approximately $33.52 per share of
common stock. The Company received net proceeds of $1,127.0 million
upon its initial sale of the debentures after deduction of issuance costs of
$23.0 million. The debt issuance costs are recorded in long-term
other assets and are being amortized to interest expense over 30
years. Interest is payable in cash semiannually in arrears on June 15
and December 15, beginning on June 15, 2008. Interest expense related
to the debentures for the first quarter of fiscal 2009 totaled $6.4 million, and
was included in interest expense on the consolidated statement of
income. The debentures also have a contingent interest component that
will require the Company to pay interest during any semiannual interest period
if the average trading price of the debenture is greater or less than certain
thresholds beginning with the semi-annual interest period commencing on December
15, 2017 (the maximum amount of contingent interest that will accrue is 0.50% of
such average trading price per year) and upon the occurrence of certain events,
as outlined in the indenture governing the debentures.
On or
after December 15, 2017, the Company may redeem all or part of the debentures
for the principal amount plus any accrued and unpaid interest if the closing
price of the Company’s common stock has been at least 150% of the conversion
price then in effect for at least 20 trading days during any 30 consecutive
trading-day period prior to the date on which the Company provides notice of
redemption.
Prior to
September 1, 2037, holders of the debentures may convert their debentures only
upon the occurrence of certain events, as outlined in the
indenture. If holders of the debentures convert their debentures in
connection with a fundamental change, as defined in the indenture, the Company
will, in certain circumstances, be required to pay a make-whole premium in the
form of an increase in the conversion rate. Additionally, in the
event of a fundamental change, the holders of the debentures may require the
Company to purchase all or a portion of their debentures at a purchase price
equal to 100% of the principal amount of debentures, plus accrued and unpaid
interest, if any.
Upon
conversion, the Company can satisfy its conversion obligation by delivering
cash, shares of common stock or any combination, at the Company’s
option. The Company intends to satisfy the lesser of the principal
amount of the debentures or the conversion value in cash. If the
conversion value of a debenture exceeds the principal amount, the Company may
also elect to deliver cash in lieu of common stock for the conversion value in
excess of one thousand dollars principal amount (conversion
spread). There would be no adjustment to the numerator in the net
income per common share computation for the cash settled portion of the
debentures as that portion of the debt instrument will always be settled in
cash. The conversion spread will be included in the denominator for
the computation of diluted net income per common share.
Under the
terms of a registration rights agreement entered into in connection with
the offering of the debentures, the Company filed a shelf registration statement
covering resales of the debentures and any common stock issuable upon conversion
of the debentures with the SEC. The Company must maintain the
effectiveness of the shelf registration statement until all of the debentures
and all shares of common stock issuable upon conversion of the debentures cease
to be outstanding, have been sold or transferred pursuant to an effective
registration statement, have been sold pursuant to Rule 144 under the Securities
Act of 1933, as amended, or the period of time specified in Rule 144 for the
holding period has passed. If the Company fails to comply with the terms
of the registration rights agreement, it will be required to pay additional
interest on the debentures at a rate per annum equal to 0.25% for the first 90
days after the date of such failure and 0.50% thereafter.
The
Company concluded the embedded features related to the contingent interest
payments, the Company making specific types of distributions (e.g.,
extraordinary dividends), the redemption feature in the event of changes in tax
law, and penalty interest in the event of a failure to maintain an effective
registration qualify as derivatives and should be bundled as a compound embedded
derivative under SFAS No. 133, Accounting for Derivative
Instruments and Hedging Activities (SFAS No. 133). Additionally, the
Company concluded the registration rights agreement entered into at the time the
Company issued the debt is a separate bifurcated derivative, however, the value
of this derivative was deemed to be immaterial, due to the low likelihood the
registration would not occur. The fair value of the compound embedded
derivative at the date of issuance of the debentures was $1.3 million and
is accounted for as a discount on the debentures. The resulting value
of the debentures of $1,148.7 million will be accreted to par value over
the term of the debt resulting in $1.3 million being amortized to interest
expense over 30 years. Any change in fair value of this embedded
derivative will be
included
in interest expense on the Company’s consolidated statements of income. The fair
value of the derivative as of June 30, 2008 was $1.6 million, compared to
the value at March 31, 2008 of $1.5 million, resulting in $0.1 million
of additional interest expense in the first quarter of fiscal
2009. The balance of the debentures on the Company’s consolidated
balance sheet at June 30, 2008 was $1,150.2 million, including the fair value of
the embedded derivative. The Company also concluded that the debentures are not
conventional convertible debt instruments and that the embedded stock conversion
option qualifies as a derivative under SFAS No. 133. In addition, in
accordance with Emerging Issues Task Force Issue No. 00-19, Accounting for Derivative Financial
Instruments Indexed to and Potentially Settled in a Company’s Own Stock,
the Company has concluded that the embedded conversion option would be
classified in stockholders’ equity if it were a freestanding
instrument. Accordingly, the embedded conversion option is not
required to be accounted for separately as a derivative.
(10)
|
Comprehensive
Income
|
Comprehensive
income consists of net income offset by net unrealized losses on
available-for-sale investments. The components of other comprehensive
loss and related tax effects were as follows (amounts in
thousands):
|
|
Three
Months Ended
June
30,
|
|
|
|
2008
|
|
|
2007
|
|
|
|
|
|
|
|
|
Increase
in unrealized losses on investments, net of tax effect of $166, and $341,
respectively
|
|
$ |
3,219 |
|
|
$ |
1,022 |
|
Comprehensive income was $79.5 million
and $81.3 million for the three months ended June 30, 2008 and June 30, 2007,
respectively.
(11)
|
Employee Benefit
Plans
|
Share-Based
Compensation Expense
The
following table presents details of share-based compensation expense resulting
from the application of SFAS No. 123R (amounts in thousands):
|
|
Three
Months Ended June 30,
|
|
|
|
2008
|
|
|
2007
|
|
Cost
of sales
|
|
$ |
1,625 |
(1) |
|
$ |
1,590 |
(1) |
Research
and development
|
|
|
2,435 |
|
|
|
2,586 |
|
Selling,
general and administrative
|
|
|
3,639 |
|
|
|
3,857 |
|
Pre-tax
effect of share-based compensation
|
|
|
7,699 |
|
|
|
8,033 |
|
Income
tax benefit
|
|
|
1,393 |
|
|
|
1,631 |
|
Net
income effect of share-based compensation
|
|
$ |
6,306 |
|
|
$ |
6,402 |
|
(1)
During the three months ended June 30, 2008, $1.4 million was capitalized
to inventory and $1.6 million of previously
capitalized inventory was sold. During
the three months ended June 30, 2007, $1.6 million was capitalized to
inventory and $1.6 million of previously capitalized inventory was
sold.
The
amount of unearned share-based compensation currently estimated to be expensed
during the remainder of fiscal 2009 through fiscal 2013 related to unvested
share-based payment awards at June 30, 2008 is
$62.6 million. The weighted average period over which the
unearned share-based compensation is expected to be recognized is approximately
2.41 years.
Combined
Incentive Plan Information
The total
intrinsic value of RSUs which vested during the three months ended June 30, 2008
was $3.9 million. The aggregate intrinsic value of RSUs
outstanding at June 30, 2008 was $83.1 million calculated based on the closing
price of the Company’s common stock of $30.54 per share on June 30,
2008. At June 30, 2008, the weighted average remaining expense
recognition period was 2.63 years.
The
weighted average fair values per share of the RSUs awarded are calculated based
on the fair market value of the Company’s common stock on the respective grant
dates discounted for the Company’s expected dividend yield. The
weighted average fair value per share of RSUs awarded in the three months ended
June 30, 2008 and 2007 was $28.07 and $32.57, respectively.
The total
intrinsic value of stock options exercised during the three months ended June
30, 2008 was $12.8 million. This intrinsic value represents the
difference between the fair market value of the Company’s common stock on the
date of exercise and the exercise price of each equity award.
The
aggregate intrinsic value of options outstanding and options exercisable at June
30, 2008 was $78.8 million and $67.4 million,
respectively. The aggregate intrinsic values were calculated based on
the closing price of the Company’s common stock of $30.54 per share on June 30,
2008.
For the
three months ended June 30, 2008 and 2007, the number of option shares
exercisable was 8,335,404 and 9,280,440, respectively, and the weighted average
exercise price per share was $22.51 and $20.93, respectively.
There
were no stock options granted in the three months ended June 30,
2008. The weighted average fair value of stock options granted in the
three months ended June 30, 2007 was $12.79 per share.
(12)
|
Net Income Per Common
Share
|
The
following table sets forth the computation of basic and diluted net income per
common share (in thousands, except per share amounts):
|
|
Three
Months Ended
June
30,
|
|
|
|
2008
|
|
|
2007
|
|
|
|
|
|
|
|
|
Net
income
|
|
$ |
76,310 |
|
|
$ |
80,293 |
|
|
|
|
|
|
|
|
|
|
Weighted
average common shares outstanding
|
|
|
184,663 |
|
|
|
218,111 |
|
Dilutive
effect of stock options
|
|
|
6,386 |
|
|
|
5,481 |
|
Dilutive
effect of convertible debt
|
|
|
1,178 |
|
|
|
--- |
|
|
|
|
|
|
|
|
|
|
Weighted
average common and common equivalent shares outstanding
|
|
|
191,049 |
|
|
|
223,592 |
|
|
|
|
|
|
|
|
|
|
Basic
net income per common share
|
|
$ |
0.41 |
|
|
$ |
0.37 |
|
|
|
|
|
|
|
|
|
|
Diluted
net income per common share
|
|
$ |
0.40 |
|
|
$ |
0.36 |
|
Diluted
net income per common share includes incremental shares issuable upon the
exchange of the debentures of 1,177,781 (see Note 9). The debentures have no
impact on diluted net income per common share unless the average price of the
Company’s common stock exceeds the conversion price because the principal amount
of the debentures will be settled in cash upon conversion. Prior to
conversion, the Company will include, in the diluted net income per common share
calculation, the effect of the additional shares that may be issued when the
Company’s common stock price exceeds the conversion price, using the treasury
stock method. The conversion price used in calculating the dilutive effect
of the convertible debt for the three months ended June 30, 2008 was $33.65 per
common share, the weighted average conversion price during the
period.
(13) Stock
Repurchase
During
the three months ended June 30, 2008, the Company purchased 0.7 million
shares of its common stock for a total of $23.6 million. During the
three months ended June 30, 2007, the Company did not repurchase any of its
shares of common stock.
As of
June 30, 2008, approximately 34.3 million shares remained as treasury shares
with the balance of the shares being used to fund share issuance requirements
under the Company’s equity incentive plans. The timing and amount of future
repurchases will depend upon market conditions, interest rates, and corporate
considerations.
On
October 28, 2002, the Company announced that its Board of Directors had approved
and instituted a quarterly cash dividend on its common stock. A
quarterly cash dividend of $0.330 per share was paid on May 24, 2008 in the
aggregate amount of $61.1 million. A quarterly cash dividend of
$0.338 per share was declared on July 24, 2008 and will be paid on August
21, 2008 to shareholders of record as of August 7, 2008. The Company
expects the August 2008 payment of its quarterly cash dividend to be
approximately $62.5 million.
|
[Remainder
of page intentionally left blank.]
|
|
Management’s
Discussion and Analysis of Financial Condition and Results of
Operations
|
This report, including “Part I –
Item 2 Management’s
Discussion and Analysis of Financial Condition and Results of
Operations” and “Part
II - Item 1A Risk Factors” contains certain forward-looking
statements that involve risks and uncertainties, including statements regarding
our strategy, financial performance and revenue sources. We use words
such as “anticipate,” “believe,” “plan,” “expect,” “future,” “intend” and
similar expressions to identify forward-looking statements. Our
actual results could differ materially from the results anticipated in these
forward-looking statements as a result of certain factors including those set
forth under “Risk Factors,” beginning at page 34 and elsewhere in this Form
10-Q. Although we believe that the
expectations reflected in the forward-looking statements are reasonable, we
cannot guarantee future results, levels of activity, performance or
achievements. You should not place undue reliance on these
forward-looking statements. We disclaim any obligation to update
information contained in any forward-looking statement. These forward-looking
statements include, without limitation, statements regarding the
following:
|
·
|
The
effects and amount of competitive pricing pressure on our product
lines;
|
|
·
|
Our
ability to moderate future average selling price
declines;
|
|
·
|
The
effect of product mix on gross
margin;
|
|
·
|
The
amount of changes in demand for our products and those of our
customers;
|
|
·
|
The
level of orders that will be received and shipped within a
quarter;
|
|
·
|
The
effect that distributor and customer inventory holding patterns will have
on us;
|
|
·
|
Our
ability to increase the proprietary portion of our analog and interface
product lines and the effect of such an
increase;
|
|
·
|
The
impact of any supply disruption we may
experience;
|
|
·
|
Our
ability to effectively utilize our facilities at appropriate capacity
levels and anticipated costs;
|
|
·
|
That
our existing facilities and planned expansion activities provide
sufficient capacity to respond to increases in
demand;
|
|
·
|
That
manufacturing costs will be reduced by transition to advanced process
technologies;
|
|
·
|
Our
ability to absorb fixed costs, labor and other direct manufacturing
costs;
|
|
·
|
Our
ability to maintain manufacturing
yields;
|
|
·
|
Continuing
our investments in new and enhanced
products;
|
|
·
|
The
ability to attract and retain qualified personnel, and the accuracy of our
assessment of the status of our employee
relations;
|
|
·
|
The
cost effectiveness of using our own assembly and test
operations;
|
|
·
|
Our
anticipated level of capital
expenditures;
|
|
·
|
The
adequacy of our patent strategy;
|
|
·
|
Continuation
of quarterly cash dividends;
|
|
·
|
The
sufficiency of our existing sources of
liquidity;
|
|
·
|
The
impact of seasonality on our
business;
|
|
·
|
The
accuracy of our estimates used in valuing employee equity
awards;
|
|
·
|
That
the resolution of legal actions will not harm our business, and the
accuracy of our assessment of the probability of loss and range of
potential loss;
|
|
·
|
That
the idling of assets will not impair the value of such
assets;
|
|
·
|
The
recoverability of our deferred tax
assets;
|
|
·
|
The
adequacy of our tax reserves to offset any potential tax liabilities,
having the appropriate support for our income tax positions and the
accuracy of our estimated tax rate;
|
|
·
|
Our
belief that the expiration of any tax holidays will not have a material
impact;
|
|
·
|
The
accuracy of our estimates of the useful life and values of our
property;
|
|
·
|
Our
ability to obtain patents and intellectual property licenses and minimize
the effects of litigation;
|
|
·
|
The
level of risk we are exposed to for product liability
claims;
|
|
·
|
The
amount of labor unrest, political instability, governmental interference
and changes in general
economic conditions that we
experience;
|
|
·
|
The
effect of fluctuations in market interest rates on income and/or cash
flows;
|
|
·
|
The
effect of fluctuations in currency
rates;
|
|
·
|
Our
ability to collect accounts
receivable;
|
|
·
|
Our
belief that the combination of distributors we have chosen will support
the needs of our customers and not adversely impact our net
sales;
|
|
·
|
Our
belief that our investments in student loan auction rate municipal bond
offerings are of high credit
quality;
|
|
·
|
Our
ability to hold our fixed income investments and auction rate securities
until the market recovers, and the immaterial impact this will have on our
liquidity;
|
|
·
|
The
accuracy of our estimation of the cost effectivity of our insurance
coverage;
|
|
·
|
Our
belief that our activities are conducted in compliance with environmental
regulations; and
|
|
·
|
Our
belief that deferred cost of sales will have low risk of material
impairment.
|
We begin
our Management’s Discussion and Analysis of Financial Condition and Results of
Operations (MD&A) with a summary of Microchip’s overall business strategy to
give the reader an overview of the goals of our business and the overall
direction of our business and products. This is followed by a
discussion of the Critical Accounting Policies and Estimates that we believe are
important to understanding the assumptions and judgments incorporated in our
reported financial results. We then discuss our Results of Operations
for the three months ended June 30, 2008 compared to the three months ended June
30, 2007. We then provide an analysis of changes in our balance sheet
and cash flows, and discuss our financial commitments in sections titled
“Liquidity and Capital Resources,” “Contractual Obligations” and “Off-Balance
Sheet Arrangements.”
Strategy
Our goal
is to be a worldwide leader in providing specialized semiconductor products for
a wide variety of embedded control applications. Our strategic focus
is on embedded control products, which include microcontrollers,
high-performance linear and mixed signal devices, power management and thermal
management devices, interface devices, Serial EEPROMs, and our patented
KeeLoq security
devices. We provide highly cost-effective embedded control products
that also offer the advantages of small size, high performance, low
voltage/power operation and ease of development, enabling timely and
cost-effective embedded control product integration by our
customers.
We sell
our products to a broad base of domestic and international customers
across a variety of industries. The principal markets that
we serve include consumer, automotive, industrial, office automation and
telecommunications. Our business is subject to fluctuations based on
economic conditions within these markets. Although our net sales in the
June 30, 2008 quarter increased from the March 31, 2008 quarter and the June 30,
2007 quarter, the recent weakness in general economic conditions has adversely
impacted our net sales to customers in the markets we
serve.
Our
manufacturing operations include wafer fabrication and assembly and
test. The ownership of our manufacturing resources is an important
component of our business strategy, enabling us to maintain a high level of
manufacturing control resulting in us being one of the lowest cost producers in
the embedded control industry. By owning our wafer fabrication
facilities and much of our assembly and test operations, and by employing
statistical process control techniques, we have been able to achieve and
maintain high production yields. Direct control over manufacturing
resources allows us to shorten our design and production cycles. This
control also allows us to capture the wafer manufacturing and a portion of the
assembly and test profit margin.
We employ
proprietary design and manufacturing processes in developing our embedded
control products. We believe our processes afford us both
cost-effective designs in existing and derivative products and greater
functionality in new product designs. While many of our competitors
develop and optimize separate processes for their logic and memory product
lines, we use a common process technology for both microcontroller and
non-volatile memory products. This allows us to more fully leverage
our process research and development costs and to deliver new products to market
more rapidly. Our engineers utilize advanced computer-aided design
(CAD) tools and software to perform circuit design, simulation and layout, and
our in house photomask and wafer fabrication facilities enable us to rapidly
verify design techniques by processing test wafers quickly and
efficiently.
We are
committed to continuing our investment in new and enhanced products, including
development systems, and in our design and manufacturing process
technologies. We believe these investments are significant factors in
maintaining our competitive position. Our current research and
development activities focus on the design of new microcontrollers, digital
signal controllers, memory and mixed-signal products, new development systems,
software and application-specific software libraries. We are also
developing new design and process technologies to achieve further cost
reductions and performance improvements in our products.
We market
our products worldwide primarily through a network of direct sales personnel and
distributors. Our distributors focus primarily on servicing the
product and technical support requirements of a broad base of diverse
customers. We believe that our direct sales personnel combined with
our distributors provide an effective means of reaching this broad and diverse
customer base. Our direct sales force focuses primarily on major
strategic accounts in three geographical markets: the Americas, Europe and
Asia. We currently maintain sales and support centers in major
metropolitan areas in North America, Europe and Asia. We believe that
a strong technical service presence is essential to the continued development of
the embedded control market. Many of our field sales engineers
(FSEs), field application engineers (FAEs), and sales management have technical
degrees and have been previously employed in an engineering
environment. We believe that the technical knowledge of our sales
force is a key competitive advantage in the sale of our products. The
primary mission of our FAE team is to provide technical assistance to strategic
accounts and to conduct periodic training sessions for FSEs and distributor
sales teams. FAEs also frequently conduct technical seminars for our
customers in major cities around the world, and work closely with our
distributors to provide technical assistance and end-user support.
Critical
Accounting Policies and Estimates
General
Our
discussion and analysis of Microchip’s financial condition and results of
operations is based upon our Consolidated Financial Statements, which have been
prepared in accordance with accounting principles generally accepted in the
United States of America. We review the accounting policies we use in
reporting our financial results on a regular basis. The preparation of
these financial statements requires us to make estimates and judgments that
affect the reported amounts of assets, liabilities, revenues and expenses and
related disclosure of contingent liabilities. On an ongoing basis, we
evaluate our estimates, including those related to revenue recognition,
share-based compensation, inventories, investments, income taxes, property plant
and equipment, impairment of property, plant and equipment, junior subordinated
convertible debentures and litigation. We base our estimates on historical
experience and on various other assumptions that are believed to be reasonable
under the circumstances, the results of which form the basis for making
judgments about the carrying value of assets and liabilities that are not
readily apparent from other sources. Results may differ from these
estimates due to actual outcomes being different from those on which we based
our assumptions. We review these estimates and judgments on an ongoing
basis. We believe the following critical accounting policies affect our
more significant judgments and estimates used in the preparation of our
consolidated financial statements. We also have other policies that we
consider key accounting policies, such as our policy regarding revenue
recognition to OEMs; however, we do not believe these policies require us to
make estimates or judgments that are as difficult or subjective as our policies
described below.
Revenue
Recognition - Distributors
Our
distributors worldwide generally have broad price protection and product return
rights, so we defer revenue recognition until the distributor sells the product
to their customer. Revenue is recognized when the distributor sells
the product to an end-user, at which time the sales price becomes fixed or
determinable. Revenue is not recognized upon shipment to our
distributors since, due to discounts from list price as well as price protection
rights, the sales price is not substantially fixed or determinable at that
time. At the time of shipment to these distributors, we record a
trade receivable for the selling price as there is a legally enforceable right
to payment, relieve inventory for the carrying value of goods shipped since
legal title has passed to the distributor, and record the gross margin in
deferred income on shipments to distributors on our consolidated balance
sheets.
Deferred
income on shipments to distributors effectively represents the gross margin on
the sale to the distributor; however, the amount of gross margin that we
recognize in future periods could be less than the deferred margin as a result
of credits granted to distributors on specifically identified
products and customers to allow the distributors to earn a competitive gross
margin on the sale of our products to their end customers and price
protection concessions related to market pricing conditions.
We sell
the majority of the items in our product catalog to our distributors worldwide
at a uniform list price. However, distributors resell our products to
end customers at a very broad range of individually negotiated price
points. The majority of our distributors’ resales require a reduction
from the original list price paid. Often, under these circumstances,
we remit back to the distributor a portion of their original purchase price
after the resale transaction is completed in the form of a credit against the
distributors’ outstanding accounts receivable balance. The credits
are on a per unit basis and are not given to the distributor until they provide
information to us regarding the sale to their end customer. The price
reductions vary significantly based on the customer, product, quantity ordered,
geographic location and other factors and discounts to a price less than our
cost have historically been rare. The effect of granting these
credits establishes the net selling price to our distributors for the product
and results in the net revenue recognized by us when the product is sold by the
distributors to their end customers. Thus, a portion of the “Deferred
income on shipments to distributors” balance represents the amount of
distributors’ original purchase price that will be credited back to the
distributor in the future. The wide range and variability of
negotiated price concessions granted to distributors does not allow us to
accurately estimate the portion of the balance in the deferred income on
shipments to distributors account that will be credited back to the
distributors. Therefore, we do not reduce deferred income on
shipments to distributors or accounts receivable by anticipated future
concessions; rather, price concessions are typically recorded against deferred
income on shipments to distributors and accounts receivable when incurred, which
is generally at the time the distributor sells the product. At June
30, 2008, we had approximately $131.8 million of deferred revenue and $34.7
million in deferred cost of sales recognized as $97.1 million of deferred income
on shipments to distributors. At March 31, 2008, we had approximately
$130.4 million of deferred revenue and $35.0 million in deferred cost of sales
recognized as $95.4 million of deferred income on shipments to
distributors. The deferred income on shipments to distributors that
will ultimately be recognized in our income statement will be lower than the
amount reflected on the balance sheet due to additional price credits to be
granted to the distributors when the product is sold to their
customers. These additional price credits historically have resulted
in the deferred income approximating the overall gross margins that we recognize
in the distribution channel of our business.
Distributor
advances, included in deferred income on shipments to distributors on our
consolidated balance sheets, totaled $36.6 million at June 30, 2008 and
$36.4 million at March 31, 2008. On sales to distributors, our
payment terms generally require the distributor to settle amounts owed to us for
an amount in excess of their ultimate cost. The sales price to our
distributors may be higher than the amount that the distributors will ultimately
owe us because distributors often negotiate price reductions after purchasing
the product from us and such reductions are often significant. It is
our practice to apply these negotiated price discounts to future purchases,
requiring the distributor to settle receivable balances, on a current basis,
generally within 30 days, for amounts originally invoiced. This
practice has an adverse impact on working capital of our
distributors. As such, we have entered into agreements with certain
distributors whereby we advance cash to the distributors to reduce the
distributor’s working capital requirements. These advances are
reconciled at least on a quarterly basis and are estimated based on the amount
of ending inventory as reported by the distributor multiplied by a negotiated
percentage. Such advances have no our impact on revenue recognition
or our consolidated statements of income. We process discounts taken
by distributors against our deferred income on shipments to distributors’
balance and true-up the advanced amounts generally after the end of each
completed fiscal quarter. The terms of these advances are set forth
in binding legal agreements and are unsecured, bear no interest on unsettled
balances and are due upon demand. The agreements governing these
advances can be cancelled by us at any time.
We reduce
product pricing through price protection based on market conditions, competitive
considerations and other factors. Price protection is granted to
distributors on the inventory they have on hand at the date the price protection
is offered. When we reduce the price of our products, it allows the
distributor to claim a credit against its outstanding accounts receivable
balances based on the new price of the inventory it has on hand as of the date
of the price reduction. There is no immediate revenue impact from the
price protection, as it is reflected as a reduction of the deferred income on
shipments to distributors’ balance.
Products
returned by distributors and subsequently scrapped have historically been
immaterial to our consolidated results of operations. We routinely
evaluate the risk of impairment of the deferred cost of sales component of the
deferred income on shipments to distributors account. Because of the
historically immaterial amounts of inventory that have been scrapped, and
historically rare instances where discounts given to a distributor result in a
price less than our cost, we believe the deferred costs are approximately
recorded at their carrying value.
Share-Based
Compensation
In the
first quarter of fiscal 2007, we adopted SFAS No. 123R, which requires
the measurement at fair value and recognition of compensation expense for all
share-based payment awards, including grants of employee stock options, RSUs and
employee stock purchase rights, to be recognized in our financial statements
based on their respective grant date fair values. Total share-based
compensation in the three months ended June 30, 2008 was $7.5 million, of
which $6.1 million was reflected in operating expenses and
$1.6 million was reflected in cost of goods sold. Total
share-based compensation which was included in inventory at June 30, 2008 was
$3.6 million.
Determining
the appropriate fair-value model and calculating the fair value of share-based
awards at the date of grant requires judgment. The fair value of our RSUs
is based on the fair market value of our common stock on the date of grant
discounted for expected future dividends. We use the Black-Scholes
option pricing model to estimate the fair value of employee stock options and
rights to purchase shares under stock participation plans, consistent with the
provisions of SFAS No. 123R. Option pricing models, including
the Black-Scholes model, also require the use of input assumptions, including
expected volatility, expected life, expected dividend rate, and expected
risk-free rate of return. We use a blend of historical and implied
volatility based on options freely traded in the open market as we believe this
is more reflective of market conditions and a better indicator of expected
volatility than using purely historical volatility. The expected life of
the awards is based on historical and other economic data trended into the
future. The risk-free interest rate assumption is based on observed interest
rates appropriate for the terms of our awards. The dividend yield
assumption is based on our history and expectation of future dividend payouts.
SFAS No. 123R requires us to develop an estimate of the number
of share-based awards which will be forfeited due to employee turnover.
Quarterly changes in the estimated forfeiture rate can have a significant
effect on reported share-based compensation, as the effect of adjusting the rate
for all expense amortization after April 1, 2006 is recognized in the period the
forfeiture estimate is changed. If the actual forfeiture rate is higher
than the estimated forfeiture rate, then an adjustment is made to increase the
estimated forfeiture rate, which will result in a decrease to the expense
recognized through the first quarter of fiscal 2009. If the actual
forfeiture rate is lower than the estimated forfeiture rate, then an adjustment
is made to decrease the estimated forfeiture rate, which will result in an
increase to the expense recognized in the financial statements. If
forfeiture adjustments are made, they would affect our gross margin, research
and development expenses, and selling, general, administrative expenses.
The effect of forfeiture adjustments through the first quarter of fiscal
2009 was immaterial.
We
evaluate the assumptions used to value our awards on a quarterly basis. If
factors change and we employ different assumptions, share-based compensation
expense may differ significantly from what we have recorded in the past.
If there are any modifications or cancellations of the underlying unvested
securities, we may be required to accelerate, increase or cancel any remaining
unearned share-based compensation expense. Future share-based compensation
expense and unearned share-based compensation will increase to the extent that
we grant additional equity awards to employees or we assume unvested equity
awards in connection with acquisitions.
Inventories
Inventories
are valued at the lower of cost or market using the first-in, first-out
method. We write down our inventory for estimated obsolescence or
unmarketable inventory in an amount equal to the difference between the cost of
inventory and the estimated market value based upon assumptions about future
demand and market conditions. If actual market conditions are less
favorable than those we projected, additional inventory write-downs may be
required. Inventory impairment charges establish a new cost basis for
inventory and charges are not subsequently reversed to income even if
circumstances later suggest that increased carrying amounts are
recoverable. In estimating our inventory obsolescence, we primarily
evaluate estimates of demand over a 12-month period and record impairment
charges for inventory on hand in excess of the estimated 12-month
demand.
Investments
We
classify our investments as trading securities or available-for-sale securities
based upon management’s intent with regard to the investments and the nature of
the underlying securities.
Our
trading securities consist of strategic investments in shares of publicly traded
common stock and restricted cash representing cash collateral for put options we
have sold on one of our trading securities. Our investments in trading
securities are carried at fair value with unrealized gains and losses reported
in other income, net.
Our
available-for-sale investments consist of government agency bonds, municipal
bonds, auction rate securities (ARS) and corporate bonds. Our investments
are carried at fair value with unrealized gains and losses reported in
stockholders’ equity. Premiums and discounts are amortized or accreted
over the life of the related available-for-sale security. Dividend and
interest income are recognized when earned. The cost of securities sold is
calculated using the specific identification method.
We
include within our short-term investments our trading securities, as well as our
income yielding available-for-sale securities that can be readily converted to
cash and includes within long-term investments those income yielding
available-for-sale securities with maturities of over one year that have
unrealized losses attributable to them. We have the ability to hold our
long-term investments until such time as these assets are no longer
impaired. Such recovery of unrealized losses is not expected to occur
within the next year.
Due to
the lack of availability of observable market quotes on certain of the our
investment portfolio of ARS, we utilize valuation models including those that
are based on expected cash flow streams and collateral values, including
assessments of counterparty credit quality, default risk underlying the
security, discount rates and overall capital market liquidity. The valuation of
our ARS investment portfolio is subject to uncertainties that are difficult to
predict. Factors that may impact our ARS valuation include changes to
credit ratings of the securities as well as to the underlying assets supporting
those securities, rates of default of the underlying assets, underlying
collateral value, discount rates, counterparty risk, the ongoing strength and
quality of the credit market and market liquidity.
The
credit markets experienced significant deterioration beginning in the second
half of fiscal 2008. If uncertainties in these markets continue, these
markets deteriorate further or we experiences any additional ratings downgrades
on any investments in our portfolio (including our ARS), we may incur additional
impairments to our investment portfolio, which could negatively affect our
financial condition, cash flow and reported earnings.
Income
Taxes
As part
of the process of preparing our consolidated financial statements, we are
required to estimate our income taxes in each of the jurisdictions in which we
operate. This process involves estimating our actual current tax exposure
together with assessing temporary differences resulting from differing treatment
of items for tax and accounting purposes. These differences result in
deferred tax assets and liabilities, which are included within our consolidated
balance sheet. We must then assess the likelihood that our deferred tax
assets will be recovered from future taxable income within the relevant
jurisdiction and to the extent we believe that recovery is not likely, we must
establish a valuation allowance. We have not provided for a valuation
allowance because we believe that it is more likely than not that our deferred
tax assets will be recovered from future taxable income. Should we
determine that we would not be able to realize all or part of our net deferred
tax asset in the future, an adjustment to the deferred tax asset would be
charged to income in the period such determination was made. At June 30,
2008, our gross deferred tax asset was $66.6 million.
Various
taxing authorities in the United States and other countries in which we do
business are increasing their scrutiny of the tax structures employed by
businesses. Companies of our size and complexity are regularly audited by
the taxing authorities in the jurisdictions in which they conduct significant
operations. We are currently under audit by the United States Internal
Revenue Service (“IRS”) for our fiscal years ended March 31, 2002, 2003 and
2004. We recognize liabilities for anticipated tax audit issues in the
United States and other tax jurisdictions based on our estimate of whether, and
the extent to which, additional tax payments are probable. We believe that
we maintain adequate tax reserves to offset any potential tax liabilities that
may arise upon these and other pending audits in the United States and other
countries in which we do business. If such amounts ultimately prove to be
unnecessary, the resulting reversal of such reserves would result in tax
benefits being recorded in the period the reserves are no longer deemed
necessary. If such amounts ultimately prove to be less than an ultimate
assessment, a future charge to expense would be recorded in the period in which
the assessment is determined.
Property,
Plant & Equipment
Property,
plant and equipment are stated at cost. Major renewals and improvements
are capitalized, while maintenance and repairs are expensed when incurred.
At June 30, 2008, the carrying value of our property and equipment totaled
$520.8 million, which represents 20.5% of our total assets. This
carrying value reflects the application of our property and equipment accounting
policies, which incorporate estimates, assumptions and judgments relative to the
useful lives of our property and equipment. Depreciation is provided on a
straight-line basis over the estimated useful lives of the related assets, which
range from 5 to 7 years on manufacturing equipment, from 10 to 15 years on
leasehold improvements and approximately 30 years on buildings.
We began
production activities at Fab 4 on October 31, 2003. We began to depreciate
the Fab 4 assets as they were placed in service for production purposes.
As of June 30, 2008, all of the buildings and supporting facilities were being
depreciated as well as the manufacturing equipment that had been placed in
service. All manufacturing equipment that was not being used in production
activities was maintained in projects in process and is not being depreciated
until it is placed into service since management believes there will be no
change to its utility from the present time until it is placed into productive
service. The lives to be used for depreciating this equipment at Fab 4
will be evaluated at such time as the assets are placed in service. We do
not believe that the temporary idling of such assets has impaired the estimated
life or carrying values of the underlying assets.
The
estimates, assumptions and judgments we use in the application of our property
and equipment policies reflect both historical experience and expectations
regarding future industry conditions and operations. The use of different
estimates, assumptions and judgments regarding the useful lives of our property
and equipment and expectations regarding future industry conditions and
operations, could result in materially different carrying values of assets and
results of operations.
Impairment
of Property, Plant and Equipment
We assess
whether indicators of impairment of long-lived assets are present. If such
indicators are present, we determine whether the sum of the estimated
undiscounted cash flows attributable to the assets in question is less than
their carrying value. If less, we recognize an impairment loss based on
the excess of the carrying amount of the assets over their respective fair
values. Fair value is determined by discounted future cash flows,
appraisals or other methods. If the assets determined to be impaired are
to be held and used, we recognize an impairment loss through a charge to our
operating results to the extent the present value of anticipated net cash flows
attributable to the asset are less than the asset’s carrying value, which we
depreciate over the remaining estimated useful life of the asset. We may incur
impairment losses, or additional losses on already impaired assets, in future
periods if factors influencing our estimates change.
Junior
Subordinated Convertible Debentures
We
account for our junior subordinated convertible debentures and related
provisions in accordance with the provisions of Emerging Issues Task Force Issue
(EITF) No. 98-5, Accounting
for Convertible Securities with Beneficial Conversion Features or Contingently
Adjustable Conversion Ratios, EITF No. 00-27, Application
of
Issue No. 98-5 to Certain
Convertible Instruments, EITF No. 00-19, Accounting for Derivative Financial
Instruments Indexed to, and Potentially Settled in, a Company’s Own
Stock, EITF No. 01-6, The Meaning of “Indexed to a
Company’s Own Stock”, and EITF No. 04-08, The Effect of Contingently
Convertible Debt on Diluted Earn. We also evaluate the
instruments in accordance with SFAS No. 133 (SFAS 133), Accounting for Derivative
Instruments and Hedging Activities, which requires bifurcation of
embedded derivative instruments and measurement of fair value for accounting
purposes. EITF No. 04-08 requires us to include the dilutive effect
of the shares of our common stock issuable upon conversion of the outstanding
junior subordinated convertible debentures in our diluted income per share
calculation regardless of whether the market price trigger or other contingent
conversion feature has been met. We apply the treasury stock method
as we have the intent and current ability to settle the principal amount of the
junior subordinated convertible debentures in cash. This method
results in incremental dilutive shares when the average fair value of our common
stock for a reporting period exceeds the conversion price per share which was
$33.52 at June 30, 2008 and adjusts as dividends are recorded in the
future.
Litigation
Our current estimated range of
liability related to pending litigation is based on the probable loss of claims
for which we can estimate the amount and range of loss. Recorded reserves
were immaterial at June 30, 2008.
Because of
the uncertainties related to both the probability of loss and the amount and
range of loss on our pending litigation, we are unable to make a reasonable
estimate of the liability that could result from an unfavorable outcome.
As additional information becomes available, we will assess the potential
liability related to our pending litigation and revise our estimates.
Revisions in our estimates of the potential liability could materially affect
our results of operation and financial position.
Results
of Operations
The
following table sets forth certain operational data as a percentage of net sales
for the periods indicated:
|
|
Three
Months Ended
June
30,
|
|
|
|
2008
|
|
|
2007
|
|
|
|
|
|
|
|
|
Net
sales
|
|
|
100.0 |
% |
|
|
100.0 |
% |
Cost
of sales
|
|
|
39.0 |
% |
|
|
40.0 |
% |
Gross
profit
|
|
|
61.0 |
% |
|
|
60.0 |
% |
Research
and development
|
|
|
11.8 |
% |
|
|
11.3 |
% |
Selling,
general and administrative
|
|
|
16.9 |
% |
|
|
16.5 |
% |
Operating
income
|
|
|
32.3 |
% |
|
|
32.2 |
% |
Net
Sales
We
operate in one industry segment and engage primarily in the design, development,
manufacture and marketing of semiconductor products. We sell our
products to distributors and original equipment manufacturers, referred to as
OEMs, in a broad range of market segments, perform ongoing credit evaluations of
our customers and generally require no collateral. In certain
circumstances, a customer’s financial condition may require collateral, and, in
such cases, the collateral would be provided primarily by letters of
credit.
Our net
sales for the quarter ended June 30, 2008 were $268.2 million, an increase
of 3.0% from the previous quarter’s sales of $260.4 million, and an increase of
1.6% from net sales of $264.1 million in the quarter ended June 30,
2007. The increases in net sales in these periods resulted primarily
from changes in market conditions across all of our product
lines. Average selling prices for our products were down
approximately 4% for the three-month period ended June 30, 2008 over the
corresponding period of the previous fiscal year. The number of units
of our products sold was up approximately 6% for the three-month period ended
June 30, 2008
over the
corresponding period of the previous fiscal year. The average selling
prices and the unit volumes of our sales are impacted by the mix of our products
sold and overall semiconductor market conditions. Key factors in
achieving the amount of net sales during the three-month period ended June 30,
2008 include:
|
·
|
increasing
semiconductor content in our customers’
products;
|
|
·
|
customers’
increasing needs for the flexibility offered by our programmable
solutions;
|
|
·
|
our
new product offerings that have increased our served available
market;
|
|
·
|
increasing
demand for our products;
|
|
·
|
continued
market share gains;
|
|
·
|
economic
conditions in the markets we serve;
and
|
|
·
|
inventory
holding patterns of our customers.
|
Sales by
product line for the three months ended June 30, 2008 and 2007 were as follows
(dollars in thousands):
|
|
Three
Months Ended June 30,
(unaudited)
|
|
|
|
2008
|
|
|
%
|
|
|
2007
|
|
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Microcontrollers
|
|
$ |
217,603 |
|
|
|
81.1 |
% |
|
$ |
213,304 |
|
|
|
80.8 |
% |
Memory
products
|
|
|
28,437 |
|
|
|
10.6 |
% |
|
|
30,291 |
|
|
|
11.5 |
% |
Analog
and interface products
|
|
|
22,132 |
|
|
|
8.3 |
% |
|
|
20,477 |
|
|
|
7.7 |
% |
Total
sales
|
|
$ |
268,172 |
|
|
|
100.0 |
% |
|
$ |
264,072 |
|
|
|
100.0 |
% |
Microcontrollers
Our
microcontroller product line represents the largest component of our total net
sales. Microcontrollers and associated application development
systems accounted for approximately 81.1% of our total net sales for the
three-month period ended June 30, 2008 compared to approximately 80.8% of
our total net sales for the three-month period ended June 30, 2007.
Net sales
of our microcontroller products increased approximately 2.0% in the three-month
period ended June 30, 2008 compared to the three-month period ended June 30,
2007. This sales increase was primarily due to increased demand for
our microcontroller products in end markets, driven principally by market share
gains and those factors described on page 24 above. The end markets
that we serve include the consumer, automotive, industrial control,
communications and computing control markets.
Historically,
average selling prices in the semiconductor industry decrease over the life of
any particular product. The overall average selling prices of our
microcontroller products have remained relatively constant over time due to the
proprietary nature of these products. We have experienced, and expect
to continue to experience, moderate pricing pressure in certain microcontroller
product lines, primarily due to competitive conditions. We have been
able to in the past, and expect to be able to in the future, moderate average
selling price declines in our microcontroller product lines by introducing new
products with more features and higher prices. We may be unable to
maintain average selling prices for our microcontroller products as a result of
increased pricing pressure in the future, which would adversely affect our
operating results.
Memory
Products
Sales of
our memory products accounted for approximately 10.6% of our total net sales for
the three-month period ended June 30, 2008 compared to approximately 11.5% of
our total net sales for the three-month period ended June 30, 2007.
Net sales
of our memory products decreased approximately 6.1% in the three-month period
ended June 30, 2008 compared to the three-month period ended June 30,
2007. This sales decrease was driven primarily by customer demand
conditions within the Serial EEPROM market which products comprise substantially
all of our memory product net sales.
Serial
EEPROM product pricing has historically been cyclical in nature, with steep
price declines followed by periods of relative price stability, driven by
changes in industry capacity at different stages of the business
cycle. We have experienced, and expect to continue to experience,
varying degrees of competitive pricing pressures in our Serial EEPROM
products. We may be unable to maintain the average selling prices of
our Serial EEPROM products as a result of increased pricing pressure in the
future, which could adversely affect our operating results.
Analog and Interface
Products
Sales of
our analog and interface products accounted for approximately 8.3% of our total
net sales for the three-month period ended June 30, 2008 compared to
approximately 7.7% of our total net sales for the three-month period ended June
30, 2007.
Net sales
of our analog and interface products increased approximately 8.1% in the
three-month period ended June 30, 2008 compared to the three-month period ended
June 30, 2007. This sales increase in our analog and interface
products was driven primarily by economic conditions, market share gains and
supply and demand conditions within the analog and interface
market.
Analog
and interface products can be proprietary or non-proprietary in
nature. Currently, we consider more than half of our analog and
interface product mix to be proprietary in nature, where prices are relatively
stable, similar to the pricing stability experienced in our microcontroller
products. The non-proprietary portion of our analog and interface
business will experience price fluctuations, driven primarily by the current
supply and demand for those products. We may be unable to maintain
the average selling prices of our analog and interface products as a result of
increased pricing pressure in the future, which would adversely affect our
operating results. We anticipate the proprietary portion of our
analog and interface products will continue to increase over time.
Distribution
Distributors
accounted for approximately 64% of our net sales in the three-month period ended
June 30, 2008 and approximately 65% of our net sales in the three-month
period ended June 30, 2007.
Our
largest distributor accounted for approximately 13% of our net sales in the
three-month period ended June 30, 2008 and 11% of our net sales in the
three-month period ended June 30, 2007.
Generally,
we do not have long-term agreements with our distributors and we, or our
distributors, may terminate our relationships with each other with little or no
advanced notice. The loss of, or the disruption in the operations of,
one or more of our distributors could reduce our future net sales in a given
quarter and could result in an increase in inventory returns.
At June
30, 2008, our distributors maintained 32 days of inventory of our products
compared to 31 days at June 30, 2007. Inventory levels at our
distributors are at the low end of our historical averages. As we
recognize revenue based on sell through for all of our distributors, we do not
believe that inventory holding patterns at our distributors will materially
impact our net sales.
Sales by
Geography
Sales by
geography for the three-month periods ended June 30, 2008 and 2007 were as
follows (dollars in thousands):
|
|
Three
Months Ended
June
30,
(unaudited)
|
|
|
|
2008
|
|
|
%
|
|
|
2007
|
|
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Americas
|
|
$ |
66,127 |
|
|
|
24.6 |
% |
|
$ |
70,406 |
|
|
|
26.7 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Europe
|
|
|
77,986 |
|
|
|
29.1 |
% |
|
|
79,842 |
|
|
|
30.2 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Asia
|
|
|
124,059 |
|
|
|
46.3 |
% |
|
|
113,824 |
|
|
|
43.1 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
sales
|
|
$ |
268,172 |
|
|
|
100.0 |
% |
|
$ |
264,072 |
|
|
|
100.0 |
% |
Our sales
to foreign customers have been predominately in Asia and Europe, which we
attribute to the manufacturing strength in those areas for automotive,
communications, computing, consumer and industrial control
products. Americas sales include sales to customers in the United
States, Canada, Mexico, Central America and South America. Sales to
customers in Asia have generally increased over time due to many of our
customers transitioning their manufacturing operations to Asia and growth in
demand from the emerging Asian market. Our sales force in the
Americas and Europe supports a significant portion of the design activity for
products which are ultimately shipped into Asia.
Sales to
foreign customers accounted for approximately 76% of our net sales in the
three-month period ended June 30, 2008 and 74% of our net sales in the
three-month period ended June 30, 2007. Substantially all of our
foreign sales are U.S. dollar denominated.
Gross
Profit
Our gross
profit was $163.6 million in the three
months ended June 30, 2008 and $158.5 million in the three months ended June 30,
2007. Gross profit as a percentage of sales was 61.0% in the three
months ended June 30, 2008 and 60.0% in the three months ended June 30,
2007.
The most
significant factors affecting our gross profit in the periods covered by this
report were:
|
·
|
lower
depreciation as a percentage of cost of sales driven by reduced capital
requirements in our business due to our purchase of Fab
4;
|
|
·
|
fluctuations
in the product mix of microcontrollers, proprietary and non-proprietary
analog products and Serial EEPROM products resulting in lower average
selling prices for our products;
and
|
|
·
|
continual
cost reductions in wafer fabrication and assembly and test manufacturing
such as new manufacturing technologies and more efficient manufacturing
techniques.
|
Other
factors that impacted our gross profit percentage in the periods covered by this
report include:
|
·
|
changes
in capacity utilization and absorption of fixed costs;
and
|
|
·
|
inventory
write-offs and the sale of inventory that was previously written
off.
|
During
the three-month period ended June 30, 2008, we operated at approximately 99% of
our Fab 2 capacity, which is approximately the same level of utilization
from the same period of the previous fiscal year. Our utilization of Fab
4’s total capacity is at relatively low levels although we are utilizing all of
the installed equipment base. We expect to maintain
approximately the same levels of capacity utilization at Fab 2 and Fab 4
during the second quarter of fiscal 2009.
The
process technologies utilized impact our gross margins. Fab 2
currently utilizes various manufacturing process technologies, but predominantly
utilizes our 0.5 to 1.0 micron processes. At June 30, 2008, Fab 4
predominantly utilized our 0.35 to 0.5 micron processes. We continue
to transition products to more advanced process technologies to reduce future
manufacturing costs. All of our production has been on 8-inch wafers
during the periods covered by this report.
Our
overall inventory levels were $125.8 million at June 30, 2008 compared to
$124.5 million at March 31, 2008. We had 110 days of inventory on our
balance sheet at June 30, 2008 compared to 112 days at March 31, 2008 and 107
days at June 30, 2007.
We
anticipate that our gross margins will fluctuate over time, driven primarily by
the overall product mix of microcontroller, analog and interface and memory
products and the percentage of net sales of each of these products in a
particular quarter, as well as manufacturing yields, fixed cost absorption,
capacity utilization levels, particularly those at Fab 4, and competitive and
economic conditions.
At June
30, 2008, approximately 67% of our assembly requirements were being performed in
our Thailand facility, compared to approximately 69% as of June 30,
2007. Third-party contractors located in Asia perform the balance of
our assembly operations. Substantially all of our test requirements
were being performed
in our
Thailand facility as of June 30, 2008 and June 30, 2007. We believe
that the assembly and test operations performed at our Thailand facility provide
us with significant cost savings when compared to contractor assembly and test
costs, as well as increased control over these portions of the manufacturing
process.
We rely
on outside wafer foundries for a relatively small portion of our wafer
fabrication requirements.
Our use
of third parties involves some reduction in our level of control over the
portions of our business that we subcontract. While we review the
quality, delivery and cost performance of our third-party contractors, our
future operating results could suffer if any third-party contractor is unable to
maintain manufacturing yields, assembly and test yields and costs at
approximately their current levels.
Research
and Development (R&D)
R&D
expenses for the three months ended June 30, 2008 were $31.6 million, or
11.8% of sales, compared to $29.7 million, or 11.3% of sales, for the three
months June 30, 2007. We are committed to investing in new and
enhanced products, including development systems software, and in our design and
manufacturing process technologies. We believe these investments are
significant factors in maintaining our competitive position. R&D
costs are expensed as incurred. Assets purchased to support our
ongoing research and development activities are capitalized when related to
products which have achieved technological feasibility, or that have alternative
future uses and are amortized over their expected useful
lives. R&D expenses include labor, depreciation, masks, prototype
wafers, and expenses for the development of process technologies, new packages,
and software to support new products and design environments.
R&D
expenses increased $1.8 million, or 6.1%, for the three months ended June
30, 2008 over the same period last year. The primary reason for the
dollar increase in R&D costs over this period was higher labor costs as a
result of expanding our internal R&D headcount.
Selling,
General and Administrative
Selling,
general and administrative expenses for the three months ended June 30, 2008
were $45.4 million,
or 16.9% of sales, compared to $43.8 million, or 16.6% of sales, for the three
months ended June 30, 2007. Selling, general and administrative
expenses include salary expenses related to field sales, marketing and
administrative personnel, advertising and promotional expenditures and legal
expenses. Selling, general and administrative expenses also include
costs related to our direct sales force and field applications engineers who
work in sales offices worldwide to stimulate demand by assisting customers in
the selection and use of our products.
Selling,
general and administrative expenses increased $1.6 million, or 3.7%, for
the three months ended June 30, 2008 over the same period last
year. The primary reason for the increase in selling, general and
administrative expenses over this period was higher labor costs as a result of
expanding our internal resources involved in the technical aspect of selling our
products.
Selling,
general and administrative expenses fluctuate over time, primarily due to
revenue and operating expense investment levels.
Other
Income (Expense)
Interest
income in the three-month period ended June 30, 2008 decreased to $10.2
million from $14.9 million in the three-month period ended June 30, 2007 as the
average interest rates on invested cash balances were at lower levels in the
three-month period ended June 30, 2008. Interest expense in the
three-month period ended June 30, 2008 was $6.4 million due to the $1.15 billion
in 2.125% junior subordinated convertible debentures we issued in December
2007. There was no interest expense in the three-month period ended
June 30, 2007. Other, net in the three-month period ended June 30,
2008 increased to $2.7 million from $0.8 million in the three-month period ended
June 30, 2007 primarily related to market fluctuations in our trading securities
and written put options as described in Note 3 to our consolidated financial
statements.
Provision
for Income Taxes
Provisions
for income taxes reflect tax on our foreign earnings and federal and state tax
on our U.S. earnings. Our effective tax rate for the three months ended
June 30,
2008 was 18.1% compared to 20.3% for the three-month period ended June 30, 2007.
The decrease in our effective tax rate was driven by the geographical mix of our
profits and the portion of our investments that are held in tax-advantaged
securities. Our effective tax rate is lower than statutory rates in the United
States due primarily to our mix of earnings in foreign jurisdictions with lower
tax rates.
Various
taxing authorities in the United States and other countries in which we do
business are increasing their scrutiny of the tax structures employed by
businesses. Companies of our size and complexity are regularly audited by
the taxing authorities in the jurisdictions in which they conduct significant
operations. We are currently under audit by the IRS for our fiscal years
ended March 31, 2002, 2003 and 2004. We recognize liabilities for
anticipated tax audit issues in the United States and other tax jurisdictions
based on our estimate of whether, and the extent to which, additional tax
payments are probable. We believe that we maintain adequate tax reserves
to offset any potential tax liabilities that may arise upon these and other
pending audits in the United States and other countries in which we do
business. If such amounts ultimately prove to be unnecessary, the
resulting reversal of such reserves would result in tax benefits being recorded
in the period the reserves are no longer deemed necessary. If such amounts
ultimately prove to be less than any final assessment, a future charge to
expense would be recorded in the period in which the assessment is
determined.
Our
Thailand manufacturing operations currently benefit from numerous tax holidays
that have been granted to us by the Thailand government based on our investments
in property, plant and equipment in Thailand. Our tax holiday periods in
Thailand expire at various times in the future. Any expiration of our tax
holidays in Thailand are expected to have a minimal impact on our overall tax
expense due to other tax holidays and increases in income in other taxing
jurisdictions with lower statutory rates.
Liquidity
and Capital Resources
We had
$1,552.7 million in cash, cash equivalents and short-term and long-term
investments at June 30, 2008, an increase of $33.6 million from the March 31,
2008 balance. The increase in cash, cash equivalents and short-term
and long-term investments over this time period is primarily attributable to
cash generated from operating activities being offset by dividends and stock
repurchase activity during the period.
Net cash
provided from operating activities was $123.1 million for the three-month
period ended June 30, 2008 which is comparable to $122.6 million for the
three-month period ended June 30, 2007.
During
the three months ended June 30, 2008, net cash provided by investing activities
was $139.8 million, compared to net cash used in investing activities of
$91.3 million for the three months ended June 30, 2007. The increase
was due primarily to changes in our net purchases, sales and maturities of
short-term and long-term investments.
We enter
into derivative transactions from time to time in an attempt to reduce our
exposure to currency rate fluctuations. Although none of the
countries in which we conduct significant foreign operations have had a highly
inflationary economy in the last five years, there is no assurance that
inflation rates or fluctuations in foreign currency rates in countries where we
conduct operations will not adversely affect our operating results in the
future. At June 30, 2008, we had foreign currency forward contracts
with a notional amount of $3.4 million outstanding.
Our level
of capital expenditures varies from time to time as a result of actual and
anticipated business conditions. Capital expenditures in the three
months ended June 30, 2008 were $21.7 million compared to $25.5 million for
the three months ended June 30, 2007. Capital expenditures are
primarily for the expansion of production capacity and the addition of research
and development equipment. We currently anticipate spending
approximately $110 million during the next 12 months to invest in equipment
and facilities to maintain, and selectively increase, capacity to meet our
currently anticipated needs, including approximately $30 million to expand our
facilities in Thailand.
We expect
to finance capital expenditures through our existing cash balances and cash
flows from operations. We believe that the capital expenditures
anticipated to be incurred over the next twelve months will provide sufficient
manufacturing capacity to meet our currently anticipated needs.
Net cash
used in financing activities was $65.0 million for the three months ended June
30, 2008 compared to $30.8 million for the three months ended June 30,
2007. Proceeds from the exercise of stock options and employee
purchases under our employee stock purchase plan were $14.4 million for the
three months ended June 30, 2008 and $21.7 million for the three
months ended June 30, 2007. We paid cash dividends to our
shareholders of $61.0 million in the three months ended June 30, 2008 and
$61.1 million in
the three months ended June 30, 2007. Excess tax benefits from
share-based payment arrangements were $5.2 million in the three months ended
June 30, 2008 and $8.7 million in the three months ended June 30,
2007.
On
December 11, 2007, we announced that our Board of Directors had authorized the
repurchase of up to an additional 10.0 million shares of our common stock in the
open market or in privately negotiated transactions. During the three months
ended June 30, 2008, we purchased 0.7 million shares of our common stock for a
total of $23.6 million. As of June 30, 2008, we had repurchased
4.3 million shares under this authorization for a total of $134.4
million. There is no expiration date associated with this
program.
Our Board
of Directors authorized the repurchase of 21.5 million shares of our common
stock in December 2007 concurrent with our junior subordinated convertible
debenture transaction for a total of $638.6 million and no further shares
are available to be repurchased under this authorization.
As of
June 30, 2008, approximately 34.3 million shares of our common stock remained as
treasury shares with the balance of the repurchased shares being used to fund
share issuance requirements under our equity incentive plans. The timing and
amount of future repurchases will depend upon market conditions, interest rates,
and corporate considerations.
On
October 28, 2002, we announced that our Board of Directors had approved and
instituted a quarterly cash dividend on our common stock. We have
continued to pay quarterly dividends and have increased the amount of such
dividends on a regular basis. A quarterly dividend of $0.330 per
share was paid on May 27, 2008 in the aggregate amount of
$61.0 million. A quarterly dividend of $0.338 per share was
declared on July 24, 2008 and will be paid on August 21, 2008 to
shareholders of record as of August 7, 2008. We expect the aggregate
August 2008 cash dividend to be approximately $62.5 million. Our
Board is free to change our dividend practices at any time and to increase or
decrease the dividend paid, or not to pay a dividend on our common stock on the
basis of our results of operations, financial condition, cash requirements and
future prospects, and other factors deemed relevant by our Board. Our
current intent is to provide for ongoing quarterly cash dividends depending upon
market conditions and our results of operations.
We
believe that our existing sources of liquidity combined with cash generated from
operations will be sufficient to meet our currently anticipated cash
requirements for at least the next 12 months. However, the
semiconductor industry is capital intensive. In order to remain
competitive, we must constantly evaluate the need to make significant
investments in capital equipment for both production and research and
development. We may seek additional equity or debt financing from
time to time to maintain or expand our wafer fabrication and product assembly
and test facilities, or for other purposes. The timing and amount of
any such financing requirements will depend on a number of factors, including
demand for our products, changes in industry conditions, product mix, and
competitive factors. There can be no assurance that such financing
will be available on acceptable terms, and any additional equity financing would
result in incremental ownership dilution to our existing
stockholders.
Contractual
Obligations
There
have not been any material changes in our contractual obligations from what we
disclosed in our Annual Report on Form 10-K for the fiscal year ended March 31,
2008.
Off-Balance
Sheet Arrangements
As of
June 30, 2008, we are not involved in any off-balance sheet arrangements, as
defined in Item 303(a)(4)(ii) of SEC Regulation S-K.
Recently Issued Accounting
Pronouncements
In
September 2006, the FASB issued Statement of Financial Accounting Standards
(SFAS) No. 157, Fair Value
Measurement (SFAS No. 157). SFAS No. 157 defines fair value,
establishes a framework for measuring fair value in accordance with generally
accepted accounting principles, and expands disclosures about fair value
measurements. In February 2008, the FASB issued FASB Staff Position (FSP)
FAS 157-2, Effective Date of
FASB Statement No. 157 (FSP FAS 157-2), which delays the effective date
of SFAS No. 157 for all nonfinancial assets and liabilities except for those
recognized or disclosed at least annually. We adopted SFAS No. 157 on April 1,
2008, which had no impact on our consolidated results of operations or financial
condition. Refer to Note 4 for additional information related to
the adoption of SFAS No. 157.
In
December 2007, the FASB issued SFAS No. 141 (revised 2007), Business Combinations (SFAS
No. 141R). SFAS No. 141R establishes principles and requirements for how
an acquirer recognizes and measures in its financial statements the identifiable
assets acquired, the liabilities assumed, any noncontrolling interest in the
acquiree and the goodwill acquired. SFAS No. 141R also establishes disclosure
requirements to enable the evaluation of the nature and financial effects of the
business combination. SFAS No. 141R is effective for fiscal years
beginning after December 15, 2008, and will be adopted by us in the first
quarter of fiscal 2010. We are currently evaluating the potential impact,
if any, of the adoption of SFAS No. 141R on our consolidated results of
operations and financial condition.
In
December 2007, the FASB issued SFAS No. 160, Noncontrolling Interests in
Consolidated Financial Statements—an amendment of Accounting Research Bulletin
No. 51 (SFAS No. 160). SFAS No. 160 establishes accounting and
reporting standards for ownership interests in subsidiaries held by parties
other than the parent, the amount of consolidated net income attributable to the
parent and to the noncontrolling interest, changes in a parent's ownership
interest, and the valuation of retained noncontrolling equity investments when a
subsidiary is deconsolidated. SFAS No. 160 also establishes
disclosure requirements that clearly identify and distinguish between the
interests of the parent and the interests of the noncontrolling owners.
SFAS No. 160 is effective for fiscal years beginning after December 15,
2008, and will be adopted by us in the first quarter of fiscal 2010. We
are currently evaluating the potential impact, if any, the adoption of SFAS 160
will have on our consolidated results of operations and financial
condition.
In March
2008, the FASB issued SFAS No. 161, Disclosures
about Derivative Instruments and Hedging Activities—an amendment of FASB
Statement No. 133 (SFAS No. 161). The standard requires additional
quantitative disclosures (provided in tabular form) and qualitative disclosures
for derivative instruments. The required disclosures include how
derivative instruments and related hedged items affect an entity’s financial
position, financial performance, and cash flows; relative volume of derivative
activity; the objectives and strategies for using derivative instruments; the
accounting treatment for those derivative instruments formally designated as the
hedging instrument in a hedge relationship; and the existence and nature of
credit-related contingent features for derivatives. SFAS No. 161 does not change
the accounting treatment for derivative instruments. SFAS No. 161 is effective
for us beginning January 1, 2009. We do not expect the adoption of SFAS
No. 161 to have a material impact on our financial condition, results of
operations or cash flows.
In May 2008, the FASB released FSP APB
14-1 Accounting For
Convertible Debt Instruments That May Be Settled in Cash Upon Conversion
(Including Partial Cash Settlement) (FSP APB 14-1) that alters the
accounting treatment for convertible debt instruments that allow for either
mandatory or optional cash settlements. FSP APB 14-1 will impact the accounting
associated with our $1.15 billion junior subordinated convertible debentures.
FSP APB 14-1 specifies that issuers of such instruments should separately
account for the liability and equity components in a manner that will reflect
the entity’s nonconvertible debt borrowing rate when interest cost is recognized
in subsequent periods, and will require us to recognize additional (non-cash)
interest expense based on the market rate for similar debt instruments without
the conversion feature. Furthermore, FSP APB 14-1 would require us to
recognize interest expense in prior periods pursuant to retrospective accounting
treatment. FSP APB 14-1 will have no impact on our actual past or
future cash flows. This FSP is effective for financial statements
issued for fiscal years beginning after December 15, 2008, and will be adopted
by us on April 1, 2009. We are currently evaluating the impact the
adoption of FSP APB 14-1 will have on our consolidated results of operations and
financial condition.
|
Quantitative
and Qualitative Disclosures About Market
Risk
|
Our
investment portfolio, consisting of fixed income securities and money market
funds and cash deposits that we hold on an available-for-sale basis, was
$1,552.7 million as of June 30, 2008, and $1,519.1 million as of March 31,
2008. These securities, like all fixed income instruments, are
subject to interest rate risk and will decline in value if market interest rates
increase. We have the ability to hold our fixed income investments
until maturity and, therefore, we would not expect to recognize any material
adverse impact in income or cash flows if market interest rates
increase.
At June 30, 2008, $59.5 million of our
investment portfolio was invested in auction rate securities. Historically, the
carrying value of auction rate securities approximated fair value due to the
frequent resetting of the interest rates. If an auction fails for amounts
we have invested, our investment will not be liquid. With the recent
liquidity issues experienced in the global credit and capital markets, our
auction rate securities have experienced multiple failed auctions. In
September 2007 and February 2008, auctions for $24.9 million and $34.8
million, respectively, of the original purchase value of our investments in
auction rate securities had failed. While we earn interest on these
investments based on a pre-determined formula with spreads tied to particular
interest rate indices, the estimated market value for a portion of these auction
rate securities no longer approximates the original purchase value.
The $24.9
million of auction rate securities that failed during September 2007 are
all AA rated by Standard & Poors and all but $2.5 million of the securities
possesses credit enhancement in the form of insurance for principal and
interest. The underlying characteristics of $22.4 million of these auction rate
securities relate to servicing statutory requirements in the life insurance
industry and $2.5 million relates to a specialty finance company that has a AAA
rating from Standard & Poors and the issue we own has a AA rating from
Standard & Poors. The $24.9 million in failed auctions have continued
to fail through the filing date of this report. As a result, we will
not be able to access such funds until a future auction on these investments is
successful. The fair value of the failed auction rate securities has been
estimated based on market information and estimates determined by management and
could change significantly based on market conditions. Based on the
estimated values, we concluded these investments were other than temporarily
impaired and recognized an impairment charge on these investments of $2.4
million during fiscal 2008 and $0.9 million during the first quarter of fiscal
2009. If the issuers are unable to successfully close future auctions or
if their credit ratings deteriorate, we may be required to further adjust the
carrying value of the investments through an impairment charge to
earnings.
The $34.8
million of auction rate securities that failed during February 2008 are
investments in student loan-backed municipal bond auction rate
securities. During the first quarter of fiscal 2009, $0.2 million of
these auction rate securities were redeemed at par by the issuer, reducing our
overall position to $34.6 million. Based upon our evaluation of
available information, we believe these investments are of high credit quality,
as all of the investments carry at least two AAA credit ratings and are largely
backed by the federal government (Federal Family Education Loan
Program). The fair value of the failed auction rate securities has
been estimated based on market information and estimates determined by
management and could change significantly based on market
conditions. However, if the issuers are not able to successfully
close future auctions or over time are not able to obtain more favorable
financing options for their debt issuance needs, including refinancing these
obligations into lower rate securities, the market value of these investments
could be negatively impacted.
Our
investment in marketable equity securities at June 30, 2008 consists of shares
of common stock, the value of which is determined by the closing price of such
shares on the respective markets on which the shares are traded as of the
balance sheet date. These investments are classified as trading securities and
accounted for under the provisions of SFAS No. 115, Accounting for Certain Investments
in Debt and Equity Securities. The market value of these investments was
approximately $14.8 million at June 30, 2008 compared to our cost basis of
approximately $13.2 million. The value of our investment in marketable equity
securities would be materially impacted if there were a significant change in
the market price of the shares. A hypothetical 30% favorable or unfavorable
change in the stock price compared to the stock price at June 30, 2008 would
have affected the value of our investment in marketable equity securities by
less than $4.5 million. Additionally, we have sold put options on one of our
trading securities, which are recorded as an accrued liability, and are marked
to market value. A decline in the stock price of the underlying
security prior to the expiration date of the puts would cause an increase to the
liability, which would result in a charge to our results of operations, and
could result in the put
being
exercised by the holder. If the put is exercised by the holder, we
could be required to pay up to $14.1 million for additional shares of the
common stock, at a price potentially in excess of the then fair market value of
the common stock. A hypothetical 30% unfavorable change in the stock
price of the trading security on which we have sold the puts, compared to the
stock price at June 30, 2008 could potentially result in the puts being
exercised and would result in our paying $14.1 million to acquire the shares of
common stock. The stock would then be marked to market value,
affecting the value of our investment by an additional
$2.1 million. See Note 3 to our consolidated financial
statements, included in Item 15(a)(1) for additional information about our
investments in marketable equity securities.
We have
international operations and are thus subject to foreign currency rate
fluctuations. To date, our exposure related to exchange rate
volatility has not been material to our operating
results. Approximately 99% of our sales are denominated in U.S.
dollars. We maintain hedges related to our foreign currency exposure
of our net investment in a foreign operation as needed. As of June
30, 2008, there were $3.4 million of foreign currency hedges outstanding
compared to no hedges outstanding as of June 30, 2007. If foreign
currency rates fluctuate by 15% from the rates at June 30, 2008, the effect on
our financial position and results of operation would be
immaterial.
During
the normal course of business we are routinely subjected to a variety of market
risks, examples of which include, but are not limited to, interest rate
movements and foreign currency fluctuations, as we discuss in this Item 7A, and
collectability of accounts receivable. We continuously assess these
risks and have established policies and procedures to protect against the
adverse effects of these and other potential exposures. Although we
do not anticipate any material losses in these risk areas, no assurance can be
made that material losses will not be incurred in these areas in the
future.
Item
4. Controls
and Procedures
Evaluation
of Disclosure Controls and Procedures
As of the
end of the period covered by this Quarterly Report on Form 10-Q, as required by
paragraph (b) of Rule 13a-15 or Rule 15d-15 under the Securities Exchange Act of
1934, as amended, we evaluated under the supervision of our Chief Executive
Officer and our Chief Financial Officer, the effectiveness of our disclosure
controls and procedures (as defined in Rules 13a-15(e) or 15d-15(e) of the
Securities Exchange Act of 1934, as amended). Based on this
evaluation, our Chief Executive Officer and our Chief Financial Officer have
concluded that our disclosure controls and procedures are effective to ensure
that information we are required to disclose in reports that we file or submit
under the Securities Exchange Act of 1934 (i) is recorded, processed, summarized
and reported within the time periods specified in Securities and Exchange
Commission rules and forms, and (ii) is accumulated and communicated to our
management, including our Chief Executive Officer and our Chief Financial
Officer, as appropriate to allow timely decisions regarding required
disclosure. Our disclosure controls and procedures are designed to
provide reasonable assurance that such information is accumulated and
communicated to our management. Our disclosure controls and
procedures include components of our internal control over financial
reporting. Management’s assessment of the effectiveness of our
internal control over financial reporting is expressed at the level of
reasonable assurance because a control system, no matter how well designed and
operated, can provide only reasonable, but not absolute, assurance that the
control system’s objectives will be met.
Changes
in Internal Control over Financial Reporting
During
the three months ended June 30, 2008, there was no change in our internal
control over financial reporting identified in connection with the evaluation
required by paragraph (d) of Rule 13a-15 or Rule 15d-15 that has materially
affected, or is reasonably likely to materially affect, our internal control
over financial reporting.
In the
ordinary course of our business, we are involved in a limited number of legal
actions, both as plaintiff
and defendant, and could incur uninsured liability in any one or more of
them. On April 18, 2008, LSI Logic and its wholly owned subsidiary
Agere, filed both an action with the International Trade
Commission and a complaint in the Eastern District of Texas alleging patent
infringement by Microchip and 17 other semiconductor and foundry
companies. These actions seek monetary damages and injunctive
relief against the allegedly infringing products. Due to
the very early stage of these proceedings, the outcome of these actions is
not presently determinable, and therefore we can make no assessment of
their materiality. Microchip intends to vigorously defend its rights in
these matters. We periodically receive notification from various
third parties alleging infringement of patents, intellectual property rights or
other matters. With respect to these and other pending legal actions
to which we are a party, although the outcome of these actions is not presently
determinable, we believe that the ultimate resolution of these matters will not
harm our business and will not have a material adverse effect on our financial
position, cash flows or results of operations. Litigation relating to
the semiconductor industry is not uncommon, and we are, and from time to time
have been, subject to such litigation. No assurances can be given
with respect to the extent or outcome of any such litigation in the
future.
When
evaluating Microchip and its business, you should give careful consideration to
the factors listed below, in addition to the information provided elsewhere in
this Form 10-Q and in other documents that we file with the Securities and
Exchange Commission.
Our
quarterly operating results may fluctuate due to factors that could reduce our
net sales and profitability.
Our
quarterly operating results are affected by a wide variety of factors that could
reduce our net sales and profitability, many of which are beyond our
control. Some of the factors that may affect our quarterly operating
results include:
|
·
|
changes
in demand or market acceptance of our products and products of our
customers;
|
|
·
|
levels
of inventories at our customers;
|
|
·
|
the
mix of inventory we hold and our ability to satisfy orders from our
inventory;
|
|
·
|
changes
in utilization of our manufacturing capacity and fluctuations in
manufacturing yields;
|
|
·
|
our
ability to secure sufficient assembly and testing
capacity;
|
|
·
|
availability
of raw materials and equipment;
|
|
·
|
competitive
developments including pricing
pressures;
|
|
·
|
the
level of orders that are received and can be shipped in a
quarter;
|
|
·
|
the
level of sell-through of our products through
distribution;
|
|
·
|
fluctuations
in the mix of products;
|
|
·
|
changes
or fluctuations in customer order patterns and
seasonality;
|
|
·
|
constrained
availability from other electronic suppliers impacting our customers’
ability to ship their products, which in turn may adversely impact our
sales to those customers;
|
|
·
|
costs
and outcomes of any current or future tax audits or any litigation
involving intellectual property, customers or other
issues;
|
|
·
|
disruptions
in our business or our customers’ businesses due to terrorist activity,
armed conflict, war, worldwide oil prices and supply, public health
concerns or disruptions in the transportation
system;
|
|
|
property
damage or other losses, whether or not covered by insurance;
and
|
|
·
|
general
economic, industry or political conditions in the United States or
internationally.
|
We
believe that period-to-period comparisons of our operating results are not
necessarily meaningful and that you should not rely upon any such comparisons as
indications of future performance. In future periods our operating results may
fall below our public guidance or the expectations of public market analysts and
investors, which would likely have a negative effect on the price of our common
stock.
Our
operating results will suffer if we ineffectively utilize our manufacturing
capacity or fail to maintain manufacturing yields.
The manufacture and assembly of
integrated circuits, particularly non-volatile, erasable CMOS memory and logic
devices such as those that we produce, are complex processes. These
processes are sensitive to a wide variety of factors, including the level of
contaminants in the manufacturing environment, impurities in the materials used,
the performance of our wafer fabrication personnel and equipment, and other
quality issues. As is typical in the semiconductor industry, we have from
time to time experienced lower than anticipated manufacturing yields. Our
operating results will suffer if we are unable to maintain yields at
approximately the current levels. This could include delays in the
recognition of revenue, loss of revenue or future orders, and customer-imposed
penalties for failure to meet contractual shipment deadlines. Our operating
results are also adversely affected when we operate at less than optimal
capacity. Lower capacity utilization results in certain costs being
charged directly to expense and lower gross margins.
We
are dependent on orders that are received and shipped in the same quarter and
are therefore limited in our visibility of future product
shipments.
Our net
sales in any given quarter depend upon a combination of shipments from backlog
and orders received in that quarter for shipment in that quarter, which we refer
to as turns orders. We measure turns orders at the beginning of a quarter
based on the orders needed to meet the shipment targets that we set entering the
quarter. Historically, we have relied on our ability to respond quickly to
customer orders as part of our competitive strategy, resulting in customers
placing orders with relatively short delivery schedules. Shorter lead
times generally mean that turns orders as a percentage of our business are
relatively high in any particular quarter and reduces our backlog visibility on
future product shipments. Turns orders correlate to overall semiconductor
industry conditions and product lead times. Because turns orders are
difficult to predict, varying levels of turns orders make our net sales more
difficult to forecast. If we do not achieve a sufficient level of turns
orders in a particular quarter relative to our revenue targets, our revenue and
operating results may suffer.
Intense
competition in the markets we serve may lead to pricing pressures, reduced sales
of our products or reduced market share.
The
semiconductor industry is intensely competitive and has been characterized by
price erosion and rapid technological change. We compete with major
domestic and international semiconductor companies, many of which have greater
market recognition and substantially greater financial, technical, marketing,
distribution and other resources than we do with which to pursue engineering,
manufacturing, marketing and distribution of their products. We may be
unable to compete successfully in the future, which could harm our
business. Our ability to compete successfully depends on a number of
factors both within and outside our control, including, but not limited
to:
|
·
|
the
quality, performance, reliability, features, ease of use, pricing and
diversity of our products;
|
|
·
|
our
success in designing and manufacturing new products including those
implementing new technologies;
|
|
·
|
the
rate at which customers incorporate our products into their own
applications;
|
|
·
|
product
introductions by our competitors;
|
|
·
|
the
number, nature and success of our competitors in a given
market;
|
|
·
|
our
ability to obtain adequate supplies of raw materials and other supplies at
acceptable prices;
|
|
·
|
our
ability to protect our products and processes by effective utilization of
intellectual property rights;
|
|
·
|
our
ability to address the needs of our customers;
and
|
|
·
|
general
market and economic conditions.
|
Historically,
average selling prices in the semiconductor industry decrease over the life of
any particular product. The overall average selling prices of our
microcontroller and proprietary analog and interface products have remained
relatively constant, while average selling prices of our Serial EEPROM and
non-proprietary analog and interface products have declined over
time.
We have
experienced, and expect to continue to experience, modest pricing declines in
certain of our more mature proprietary product lines, due primarily to
competitive conditions. We have been able to moderate
average
selling price declines in many of our proprietary product lines by continuing to
introduce new products with more features and higher prices. However,
there can be no assurance that we will be able to do so in the future. We
have experienced in the past and expect to continue to experience in the future
varying degrees of competitive pricing pressures in our Serial EEPROM and
non-proprietary analog products.
We may be
unable to maintain average selling prices for our products as a result of
increased pricing pressure in the future, which could adversely impact our
operating results.
Our
business is dependent on selling through distributors.
Sales
through distributors accounted for approximately 64% of our net sales in fiscal
2008 and the first three months of fiscal 2009. Our largest
distributor accounted for approximately 12% of our net sales in fiscal 2008 and
13% of our net sales in the first three months of fiscal 2009. We do
not have long-term agreements with our distributors and we and our distributors
may each terminate our relationship with little or no advance
notice.
On
February 4, 2008, we terminated our distributor Arrow Electronics and
announced that we had partnered with Avnet Electronics Marketing and Future
Electronics to provide our global distribution services. We believe that
these two global distributors combined with our regional and specialty
distributor partners will have a positive long-term impact in supporting the
technical and commercial support needs of our customers. Our net sales of
products sold by Arrow Electronics in the fiscal year ended March 31, 2008
represented approximately 7% of our net sales. Although we do not believe
the termination of Arrow Electronics will have a material adverse impact on our
net sales, there can be no assurance as to what the long-term or short-term
impact on us will be as a result of these recent actions.
Our
success depends on our ability to introduce new products on a timely
basis.
Our
future operating results will depend on our ability to develop and introduce new
products on a timely basis that can compete effectively on the basis of price
and performance and which address customer requirements. The success of
our new product introductions depends on various factors, including, but not
limited to:
|
·
|
proper
new product selection;
|
|
·
|
timely
completion and introduction of new product
designs;
|
|
·
|
availability
of development and support tools and collateral literature that make
complex new products easy for engineers to understand and use;
and
|
|
·
|
market
acceptance of our customers’ end
products.
|
Because
our products are complex, we have experienced delays from time to time in
completing development of new products. In addition, our new products may not
receive or maintain substantial market acceptance. We may be unable to
design, develop and introduce competitive products on a timely basis, which
could adversely impact our future operating results.
Our
success also depends upon our ability to develop and implement new design and
process technologies. Semiconductor design and process technologies
are subject to rapid technological change and require significant R&D
expenditures. We and other companies in the industry have, from time
to time, experienced difficulties in effecting transitions to advanced process
technologies and, consequently, have suffered reduced manufacturing yields or
delays in product deliveries. Our future operating results could be
adversely affected if any transition to future process technologies is
substantially delayed or inefficiently implemented.
We
must attract and retain qualified personnel to be successful, and competition
for qualified personnel is intense in our market.
Our success depends upon the efforts
and abilities of our senior management, engineering and other personnel.
The competition for qualified engineering and management personnel is
intense.
We may be
unsuccessful in retaining our existing key personnel or in attracting and
retaining additional key personnel that we require. The loss of the
services of one or more of our key personnel or the inability to add key
personnel could harm our business. We have no employment agreements
with any member of our senior management team. As a result of the
anticipated impact that the adoption of SFAS No. 123R
in our first fiscal quarter of 2007 would have on our results of operations, we
changed our equity compensation program during fiscal 2006. We now grant
fewer equity-based shares per employee and the type of equity instrument is
generally restricted stock units rather than stock options. This
change in our equity compensation program may make it more difficult for us to
attract or retain qualified management and engineering personnel, which could
have an adverse effect on our business.
We
are dependent on several contractors to perform key manufacturing functions for
us.
We use
several contractors located in Asia for a portion of the assembly and testing of
our products. We also rely on outside wafer foundries for a portion of our wafer
fabrication. Although we own the majority of our manufacturing resources,
the disruption or termination of any of our contractors could harm our business
and operating results.
Our use
of third parties involves some reduction in our level of control over the
portions of our business that we subcontract. Our future operating results
could suffer if any contractor were to experience financial, operations or
production difficulties or situations when demand exceeds capacity, or if they
were unable to maintain manufacturing yields, assembly and test yields and costs
at approximately their current levels, or if due to their locations in foreign
countries they were to experience political upheaval or infrastructure
disruption. Further, procurement of required products and services from
third parties is done by purchase order and contracts. If these third
parties are unable or unwilling to timely deliver products or services
conforming to our quality standards, we may not be able to qualify additional
manufacturing sources for our products in a timely manner or at all, and such
arrangements, if any, may not be on favorable terms to us. In such event,
we could experience an interruption in production, an increase in manufacturing
and production costs, decline in product reliability, and our business and
operating results could be adversely affected.
We
may lose sales if our suppliers of raw materials and equipment fail to meet our
needs.
Our
semiconductor manufacturing operations require raw materials and equipment that
must meet exacting standards. We generally have more than one source for
these supplies, but there are only a limited number of suppliers capable of
delivering various raw materials and equipment that meet our standards.
The raw materials and equipment necessary for our business could become more
difficult to obtain as worldwide use of semiconductors in product applications
increases. We have experienced supply shortages from time to time in the
past, and on occasion our suppliers have told us they need more time than
expected to fill our orders or that they will no longer support certain
equipment with updates or spare and replacements parts. An interruption of
any raw materials or equipment sources, or the lack of supplier support for a
particular piece of equipment, could harm our business.
Our
operating results may be impacted by both seasonality and the wide fluctuations
of supply and demand in the semiconductor industry.
The
semiconductor industry is characterized by seasonality and wide fluctuations of
supply and demand. Since a significant portion of our revenue is from
consumer markets and international sales, our business may be subject to
seasonally lower revenues in the third and fourth quarters of our fiscal
year. However, fluctuations in our overall business in certain recent
periods and semiconductor industry conditions have had a more significant impact
on our results than seasonality, and has made it difficult to assess the impact
of seasonal factors on our business. The industry has also experienced
significant economic downturns, characterized by diminished product demand and
production over-capacity. We have sought to reduce our exposure to this
industry cyclically by selling proprietary products that cannot be easily or
quickly replaced, to a geographically diverse base of customers across a broad
range of market segments. However, we have experienced substantial
period-to-period fluctuations in operating results and expect, in the future, to
experience period-to-period fluctuations in operating results due to general
industry or economic conditions.
We
are exposed to various risks related to legal proceedings or
claims.
We are
currently, and in the future may be, involved in legal proceedings or claims
regarding patent infringement, intellectual property rights, contracts and other
matters. As is typical in the semiconductor industry, we receive
notifications from customers from time to time who believe that we owe them
indemnification or other obligations related to infringement claims made against
the customers by third parties. These legal proceedings and claims,
whether with or without merit, could result in substantial cost to us and divert
our resources. If we are not able to resolve a claim, negotiate a
settlement of a matter, obtain necessary licenses on commercially reasonable
terms, reengineer our products or processes to avoid infringement, and/or
successfully prosecute or defend our position, we could incur uninsured
liability in any of them, be required to take an appropriate charge to
operations, be enjoined from selling a material portion of our product lines or
using certain processes, suffer a reduction or elimination in value of
inventories, and our business, financial condition or results of operations
could be harmed.
It is
also possible that from time to time we may be subject to claims related to the
performance or use of our products. These claims may be due to
products nonconformance to our specifications, or specifications agreed upon
with the customer, changes in our manufacturing processes, and unexpected end
customer system issues due to the interaction with our products or insufficient
design or testing by our customers. We could incur significant
expenses related to such matters, including costs related to writing off the
value of inventory of defective products; recalling defective products;
providing support services, product replacements, or modification to products;
the defense of such claims; diversion of resources from other projects; lost
revenue or delay in recognition of revenue due to cancellation of orders and
unpaid receivables; customer imposed fines or penalties for failure to meet
contractual requirements; and a requirement to pay damages.
Because
the systems into which our products are integrated have a higher cost of goods
than the products we sell, these expenses and damages may be significantly
higher than the sales and profits we received from the products involved.
While we specifically exclude consequential damages in our standard terms and
conditions, our ability to avoid such liabilities may be limited by applicable
law. We do have product liability insurance, but we do not expect that
insurance will cover all claims or be of a sufficient amount to fully protect
against such claims. Costs or payments we may make in connection with
these customer claims may adversely affect the results of our
operations.
Further,
we sell to customers in industries such as automotive, aerospace, and medical,
where failure of the systems in which our products are used could cause damage
to property or persons. We may be subject to customer claims if our
products, or interactions with our products, cause the system failures. We
will face increased exposure to customer claims if there are substantial
increases in either the volume of our sales into these applications or the
frequency of system failures caused by our products.
Failure
to adequately protect our intellectual property could result in lost revenue or
market opportunities.
Our
ability to obtain patents, licenses and other intellectual property rights
covering our products and manufacturing processes is important for our success.
To that end, we have acquired certain patents and patent licenses and intend to
continue to seek patents on our inventions and manufacturing processes.
The process of seeking patent protection can be long and expensive, and patents
may not be issued from currently pending or future applications. In
addition, our existing patents and any new patents that are issued may not be of
sufficient scope or strength to provide meaningful protection or any commercial
advantage to us. We may be subject to or may ourselves initiate
interference proceedings in the U.S. Patent and Trademark Office, which can
require significant financial and management resources. In addition, the
laws of certain foreign countries do not protect our intellectual property
rights to the same extent as the laws of the United States. Infringement
of our intellectual property rights by a third party could result in
uncompensated lost market and revenue opportunities for us.
We
do not typically have long-term contracts with our customers.
We do not typically enter into
long-term contracts with our customers and we cannot be certain about future
order levels from our customers. When we do enter into customer contracts,
the contract is generally cancelable at the convenience of the customer.
Even though we have approximately 63,000 end customers and our ten largest
customers made up approximately 9% of our total revenue for the three months
ended June 30, 2008, cancellation of customer contracts could have an adverse
financial impact on our revenue and profits.
Further,
as the practice has become more commonplace in the industry, we have entered
into contracts with certain customers that differ from our standard terms of
sale. Under these contracts we commit to supply quantities of products on
scheduled delivery dates. If we become unable to supply the customer as
required under the contract, the customer may incur additional production costs,
lost revenues due to subsequent delays in their own manufacturing schedule, or
quality related issues. Under these contracts, we may be liable for the
costs the customer has incurred. While we try to limit such liabilities,
if they should arise, there may be a material adverse impact on our results of
operation and financial condition.
Business
interruptions could harm our business.
Operations
at any of our manufacturing facilities, or at any of our wafer fabrication or
assembly and test subcontractors, may be disrupted for reasons beyond our
control, including work stoppages, power loss, incidents of terrorism or
security risk, political instability, public health issues, telecommunications,
transportation or other infrastructure failure, fire, earthquake, floods, or
other natural disasters. If operations at any of our facilities, or our
subcontractors’ facilities are interrupted, we may not be able to shift
production to other facilities on a timely basis. If this occurs, we would
likely experience delays in shipments of products to our customers and alternate
sources for production may be unavailable on acceptable terms. This could
result in reduced revenues and profits and the cancellation of orders or loss of
customers. In addition, business interruption insurance will likely not be
enough to compensate us for any losses that may occur and any losses or damages
incurred by us as a result of business interruptions could significantly harm
our business.
We
are highly dependent on foreign sales and operations, which exposes us to
foreign political and economic risks.
Sales to
foreign customers account for a substantial portion of our net sales.
During fiscal 2008, approximately 75% of our net sales were made to foreign
customers. During the first three months of fiscal 2009,
approximately 76% of our net sales were made to foreign customers. We
purchase a substantial portion of our raw materials and equipment from foreign
suppliers. In addition, we own product assembly and testing facilities
located near Bangkok, Thailand, which has experienced periods of political
uncertainty in the past. We also use various foreign contractors for a
portion of our assembly and testing and for a portion of our wafer fabrication
requirements. Substantially all of our finished goods inventory is
maintained in Thailand.
Fluctuations
in foreign currency could impact our operating results. We use
forward currency exchange contracts to reduce the adverse earnings impact from
the effect of exchange rate fluctuations on our non-U.S. dollar net balance
sheet exposures. Nevertheless, in periods when the U.S. dollar
significantly fluctuates in relation to the non-U.S. currencies in which we
transact business, the value of non-U.S. dollar transactions can have an adverse
effect on our results of operations and financial condition.
Our
reliance on foreign operations, foreign suppliers, maintenance of substantially
all of our finished goods inventory at foreign locations and significant foreign
sales exposes us to foreign political and economic risks, including, but not
limited to:
|
·
|
political,
social and economic instability;
|
|
·
|
public
health conditions;
|
|
·
|
trade
restrictions and changes in
tariffs;
|
|
·
|
import
and export license requirements and
restrictions;
|
|
·
|
difficulties
in staffing and managing international
operations;
|
|
·
|
employment
regulations;
|
|
·
|
disruptions
in international transport or
delivery;
|
|
·
|
difficulties
in collecting receivables;
|
|
·
|
economic
slowdown in the worldwide markets served by us;
and
|
|
·
|
potentially
adverse tax consequences.
|
If any of
these risks materialize, our sales could decrease and/or our operating results
could suffer.
If
recent credit market conditions continue or worsen, it could have a material
adverse impact on the value or liquidity of our investment portfolio, including
our holdings of auction rate securities.
At June
30, 2008, $59.5 million of our investment portfolio was invested in auction rate
securities. Historically, the carrying value of auction rate securities
approximated fair value due to the frequent resetting of the interest
rates. With the recent liquidity issues experienced in the global credit
and capital markets, our auction rate securities have experienced multiple
failed auctions. As a result, we will not be able to access such funds
until a future auction on these investments is successful. The fair value
of the failed auction rate securities has been estimated based on market
information and estimates determined by our management and could change
significantly based on market conditions. Based on the estimated values,
we concluded these investments were other than temporarily impaired and
recognized impairment charges on these investments of $2.4 million in fiscal
2008 and $0.9 million during the first quarter of fiscal 2009. We continue
to monitor the market for auction rate securities and consider its impact, if
any, on the fair market value of our investments. If the issuers are
unable to successfully close future auctions or if their credit ratings
deteriorate, we may be required to further adjust the carrying value of the
investments through an impairment charge to earnings.
The substantial
majority of our short and long-term investments are in highly rated government
agency bonds and municipal bonds. Other than with respect to our holdings
of auction rate securities, we have not experienced any liquidity or impairment
issues with such investments. However, the credit markets have continued
to be quite volatile and there can be no assurance that these conditions will
not in the future adversely affect the liquidity or value of our investments in
government agency bonds or municipal bonds.
Interruptions
in information technology systems could adversely affect our
business.
We rely
on the efficient and uninterrupted operation of complex information technology
systems and networks to operate our business. Any significant system or
network disruption, including but not limited to computer viruses, security
breaches, or energy blackouts could have a material adverse impact on our
operations, sales and operating results. We have implemented measures to
manage our risks related to such disruptions, but such disruptions could
negatively impact our operations and financial results. In addition, we
may incur additional costs to remedy the damages caused by these disruptions or
security breaches.
The
occurrence of events for which we are self-insured, or which exceed our
insurance limits, may adversely affect our profitability and
liquidity.
We have
insurance contracts with independent insurance companies related to many
different types of risk; however, we self-insure for some risks and obligations.
In these circumstances, we have determined that it is more cost effective to
self-insure certain risks than to pay the increased premium costs in place since
the disruption in the insurance market after the events of September 11,
2001. The risks and exposures that we self-insure include, but are not
limited to, certain property, product defects, political risks, and patent
infringement. Should there be a loss or adverse judgment or other decision
in an area for which we are self-insured, then our financial condition, result
of operations and liquidity may be adversely affected.
We
are subject to stringent environmental regulations, which may force us to incur
significant expenses.
We must
comply with many different federal, state, local and foreign governmental
regulations related to the use, storage, discharge and disposal of toxic,
volatile or otherwise hazardous chemicals used in our products and manufacturing
process. Our failure to comply with present or future regulations could
result in the imposition of fines, suspension of production or a cessation of
operations. Such environmental regulations have required us in the past
and could require us in the future to acquire costly equipment or to incur other
significant expenses to comply with such regulations. Any failure by us to
control the use of or adequately restrict the discharge of hazardous substances
could subject us to future liabilities. Environmental problems may occur
that could subject us to future costs or liabilities.
Over the
past few years, there has been an expansion in environmental laws focusing on
reducing or eliminating hazardous substances in electronic products. For
example, the EU RoHS Directive provided that beginning July 1, 2006,
electronic products sold into Europe were required to meet stringent chemical
restrictions, including the absence of lead. Other countries, such as the
United States, China and Korea, have enacted or may enact laws or regulations
similar to those of the EU. These and other future environmental
regulations could require us to reengineer certain of our existing products and may make it more expensive for us to manufacture and
sell our products. Over the last several years, the number and
complexity of laws focused on the energy efficiency of electronic products and
accessories; the recycling of electronic products; and the reduction in quantity
and the recycling of packaging materials have expanded
significantly. It may be difficult for us to timely comply with these
laws and we may not have sufficient quantities of compliant materials to meet
customers’ needs, thereby adversely impacting our sales and profitability.
We may also have to write off inventory in the event that we hold inventory that
is not saleable as a result of changes to regulations. We expect
these trends to continue. In addition, we anticipate increased
customer requirements to meet voluntary criteria related to reduction or
elimination of hazardous substances in our products and energy efficiency
measures.
Regulatory
authorities in jurisdictions into which we ship our products could levy fines or
restrict our ability to export products.
A
significant portion of our sales are made outside of the United States through
the exporting and re-exporting of products. In addition to local
jurisdictions’ export regulations, our U.S. manufactured products or products
based on U.S. technology are subject to Export Administration Regulations
(“EAR”) when exported and re-exported to and from all international
jurisdictions. Licenses or proper license exceptions may be required for
the shipment of our products to certain countries. Non-compliance with the
EAR or other export regulations can result in penalties including denial of
export privileges, fines, criminal penalties, and seizure of products.
Such penalties could have a material adverse effect on our business including
our ability to meet our net sales and earnings targets.
The
outcome of currently ongoing and future examinations of our income tax returns
by the IRS could have an adverse effect on our results of
operations.
We are
subject to continued examination of our income tax returns by the Internal
Revenue Service and other tax authorities for fiscal year 2002 and later.
We regularly assess the likelihood of adverse outcomes resulting from these
examinations to determine the adequacy of our provision for income taxes.
There can be no assurance that the outcomes from these continuing examinations
will not have an adverse effect on our future operating results.
The
future trading price of our common stock could be subject to wide fluctuations
in response to a variety of factors.
The
market price of our common stock has fluctuated significantly in the past and is
likely to fluctuate in the future. The future trading price of our
common stock could be subject to wide fluctuations in response to a variety of
factors, many of which are beyond our control, including, but not limited
to:
|
·
|
quarterly
variations in our operating results and the operating results of other
technology companies;
|
|
·
|
actual
or anticipated announcements of technical innovations or new products by
us or our competitors;
|
|
·
|
changes
in analysts’ estimates of our financial performance or buy/sell
recommendations;
|
|
·
|
changes
in our financial guidance or our failure to meet such
guidance;
|
|
·
|
general
conditions in the semiconductor industry;
and
|
|
·
|
worldwide
economic and financial conditions.
|
In
addition, the stock market has experienced significant price and volume
fluctuations that have particularly affected the market prices for many high
technology companies and that often have been unrelated to the operating
performance of such companies. These broad market fluctuations and
other factors may harm the market price of our common stock.
In
the event we make acquisitions, we may not be able to successfully integrate
such acquisitions or attain the anticipated benefits.
While
acquisitions do not represent a major part of our growth strategy, from time to
time we may consider strategic acquisitions if such opportunities arise.
Any transactions that we complete may involve a number of risks, including: the
diversion of our management’s attention from our existing business to integrate
the operations and personnel of the acquired business, or possible adverse
effects on our operating results during the integration process. In
addition, we may not be able to successfully or profitably integrate, operate,
maintain and manage any newly acquired operations or employees. We may not
be able to maintain uniform standards, controls, procedures and policies, and
this may lead to operational inefficiencies.
We
have not historically maintained substantial levels of indebtedness, and our
financial condition and results of operations could be adversely affected if we
do not effectively manage our liabilities.
As a
result of our sale of $1.15 billion of 2.125% junior subordinated
convertible debentures in December 2007, we have a substantially greater amount
of long-term debt than we have maintained in the past. Our maintenance of
substantial levels of debt could adversely affect our flexibility to take
advantage of corporate opportunities and could adversely affect our financial
condition and results of operations. We may need or desire to
refinance all or a portion of our debentures or any other future indebtedness
that we incur on or before the maturity of the debentures. There can
be no assurance that we will be able to refinance any of our indebtedness on
commercially reasonable terms, if at all.
Conversion
of our debentures will dilute the ownership interest of existing stockholders,
including holders who had previously converted their debentures.
The
conversion of some or all of our outstanding debentures will dilute the
ownership interest of existing stockholders to the extent we deliver common
stock upon conversion of the debentures. Upon conversion, we may
satisfy our conversion obligation by delivering cash, shares of common stock or
any combination, at our option. If upon conversion we elect to
deliver cash for the lesser of the conversion value and principal amount of the
debentures, we would pay the holder the cash value of the applicable number of
shares of our common stock. If the conversion value of a debenture
exceeds the principal amount of the debenture, we may also elect to deliver in
cash in lieu of common stock for the conversion value in excess of one thousand
dollars principal amount (conversion spread). There would be no
adjustment to the numerator in the net income per common share computation for
the cash settled portion of the debentures as that portion of the debt
instrument will always be settled in cash. The conversion spread will
be included in the denominator for the computation of diluted net income per
common share. Any sales in the public market of any common stock
issuable upon such conversion could adversely affect prevailing market prices of
our common stock. In addition, the existence of the debentures may
encourage short selling by market participants because the conversion of the
debentures could be used to satisfy short positions, or anticipated conversion
of the debentures into shares of our common stock could depress the price of our
common stock.
There
will likely be potential new accounting pronouncements or regulatory rulings
which may have an adverse impact on our future financial condition and results
of operations.
There
will likely be potential new accounting pronouncements of regulatory rulings,
which may have an adverse impact on our future financial condition and results
of operations. For example, in May 2008, the FASB issued FASB Staff
Position (FSP) No. APB 14-1, Accounting for Convertible Debt
Instruments that May be Settled in Cash Upon Conversion (Including Partial
Cash Settlement) (FSP APB 14-1), that alters the accounting
treatment for convertible debt that allows for either mandatory or optional cash
settlements, including our outstanding debentures. The FSP requires
the issuer to separately account for the liability and equity components of the
instrument in a manner that reflects the issuer’s economic interest
cost. Further, the FSP will require bifurcation of a component of the
debt, classification of that component as equity, and then accretion of the
resulting discount on the debt to result in the “economic interest cost” being
reflected in the condensed consolidated statements of operations. In
issuing this FSP, the FASB emphasized that the FSP will be applied to the terms
of the instruments as they existed for the time periods, therefore, the
application of the FSP would be applied retrospectively to all periods
presented. The FSP is effective for fiscal years beginning after
December 15, 2008, and will require retrospective application. We
will be required to implement the proposed standard during the first quarter of
fiscal 2010, which begins on April 1, 2009. Although FSP APB 14-1
will
have no
impact on our actual past or future cash flows, it would require us to record a
significant amount of non-cash interest expense as the debt discount is
amortized. In addition, if our convertible debt is redeemed or
converted prior to maturity, any unamortized debt discount would result in a
loss on extinguishment. As a result, there could be a material
adverse impact on our results of operations and earnings per
share. These impacts could adversely affect the trading price of our
common stock and the trading price of our debentures.
The following table sets forth
our purchases of our common stock in the first quarter of fiscal 2009 and the
footnote below the table designates the repurchase program that the shares were
purchased under:
Issuer
Purchases of Equity Securities
|
|
Period
|
|
(a)
Total Number of Shares Purchased
|
|
|
(b)
Average Price Paid per Share
|
|
|
(c)
Total Number of Shares Purchased as Part of Publicly Announced
Programs
|
|
|
(d)
Maximum Number of Shares that May Yet Be Purchased Under the Programs
(1)
|
|
April
1 – April 30, 2008
|
|
|
--- |
|
|
|
--- |
|
|
|
--- |
|
|
|
6,492,234 |
|
May
1 – May 31, 2008
|
|
|
--- |
|
|
|
--- |
|
|
|
--- |
|
|
|
6,492,234 |
|
June
1 – June 30, 2008
|
|
|
749,400 |
|
|
$ |
31.54 |
|
|
|
749,400 |
|
|
|
5,742,834 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) On
December 11, 2007, our Board of Directors authorized the repurchase of up
to 10 million shares of our common stock in open market or privately
negotiated transactions. As of June 30, 2008, 5,742,834 shares of
this authorization remained available to be purchased under this
program. There is no expiration date associated with this
program.
|
|
|
31.1
|
Certification
of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley
Act of 2002.
|
|
|
31.2
|
Certification
of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley
Act of 2002.
|
|
|
32
|
Certification
of Chief Executive Officer and Chief Financial Officer Pursuant to Section
906 of the Sarbanes-Oxley Act of
2002.
|
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned thereunto
duly authorized.
|
MICROCHIP
TECHNOLOGY INCORPORATED
|
|
|
|
|
Date: August
7, 2008
|
By: /s/ Gordon W.
Parnell
|
|
Gordon W.
Parnell
|
|
Vice President and Chief
Financial Officer
|
|
(Duly Authorized Officer,
and
|
|
Principal Financial
and Accounting Officer)
|